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ABSTRACT

Various materials, such as gold and tantalum oxide, have been researched for their use as
radiation enhancers or “radiosensitisers” with high Z elements showing a high proficiency.
Bismuth oxide nanoceramics have been utilised in many applications but their effectiveness
as a high Z radiosensitiser has not yet been examined. The aim of this investigation was to
assess the effectiveness of Bi2O3 nanoceramics as radiation enhancers and to tailor the
biochemical activity through oxygen deficiencies. These were tested on 9L Gliosarcoma and
Madin-Darby canine kidney (MDCK) cell lines. The nanoceramics were characterised using
X-ray diffraction and electron microscopy to confirm 50-80 nm nanoplatelet morphology and
monoclinic crystal structure. The surfaces of the nanoceramics were then examined for
atomic composition which showed oxygen reduction of 1.25 weight% in the argon annealed
nanoceramic. Different biological behaviours were observed between the two samples. The
air annealed samples showing cytotoxicity, while the argon annealed samples demonstrated
cell proliferation and biocompatibility for MDCK and 9L respectively. Bioactivity was linked
to the generation and scavenging of reactive oxygen species (ROS), with the effects dictated
by available oxygen deficiencies and exposure time. The nanoceramics were then examined
under 125 kV and 10 MV radiation energies. Under the 125 kVp energy, both the air and
argon nanoceramics had the same calculated sensitisation enhancement ratio (SER). The
more effective argon sample was examined under a 10 MV field and demonstrated an SER of
1.25. The platelet structure of the nanoceramics results in a kV SER higher than other
compounds published, but it hinders the 10 MV effectiveness due to the aggregate size
trapping the produced electrons in the material. Future research would involve optimising the
morphology for smaller platelets with increased oxygen deficiencies, examination at multiple
radiation energies, and incorporation into a theranostic system.

ii

STATEMENT OF ORIGINALITY

This is to certify that the work described in this thesis is entirely my own, except where due
reference is made in the text.

No work in this thesis has been submitted for a degree to any other university or institution.

Signed

Callum A.C Stewart
July 2014

iii

ACKNOWLEDGEMENTS

Firstly, I would like to thank Moeava and Kosta for providing the opportunity to work
on an interesting multidisciplinary project. Moeava, your knowledge and experience in
cellular biology and radiation physics was irreplaceable, without which the project would not
have succeeded. Kosta, your materials expertise is unparalleled and your willingness to help
students has allowed me discover a passion I will carry with me for a very long time. I would
like to thank both of you for your encouragement at times when the stress was mounting up
and I was losing motivation and for the continual advice and guidance you have provided,
often late at night and on weekends.
Secondly, I would like to thank the other supervisors of the targeted nanotherapies
(T.N.T.) team. Michael, I would like to thank you for your expertise and unique perspectives
on the work. They have led to insights and solutions that were not obvious to everyone else.
Stéphanie, thank you for your willingness to help all T.N.T. with radiation experiments,
almost exclusively on weekends. It is greatly appreciated.
To my fellow T.N.T. members, it has been both a privilege and an honour to work
with such a helpful and friendly group of people. Sianne and Ryan, thank you for teaching me
the intricacies of cell culture procedures as I was starting out in this project. Marjorie and
Lee, thank you for being a sympathetic ear at time when I felt stressed and for the company
during the long nights of radiation experiments. Dean, I would like to thank you very much
for being my secondary pair of eyes on the occasions when I needed help in writing and
editing. Kathrin, despite being involved in T.N.T. for only a few months you have been a
good friend and double checker for experiments. I hope to be working with you all again and
wish you a prosperous and fulfilling future.
Lastly I would like to thank my family and friends for their understanding and
support. I know that my conversations have been focussed primarily around my project and I
have missed quite a few social events because of work. I thank you for tolerating all the
technical talk and venting and caring about me anyway, it has made the last 2 years possible.

iv

TABLE OF CONTENTS
ABSTRACT ...............................................................................................................................ii
Statement of Originality........................................................................................................... iii
ACKNOWLEDGEMENTS ...................................................................................................... iv
TABLE OF CONTENTS ........................................................................................................... v
LIST OF FIGURES ............................................................................................................... viii
LIST OF TABLES ..................................................................................................................... x
List of Abbreviations ................................................................................................................ xi
1. Project Aims and Objectives .................................................................................................. 1
2. Literature Review ................................................................................................................... 2
2.1

Radiation therapy ....................................................................................................... 2

2.1.1

History.................................................................................................................. 2

2.1.2

Damage Mechanisms ........................................................................................... 3

2.1.3

Cellular response to Radiotherapy ..................................................................... 5

2.1.4

Reactive Oxygen Species (ROS) and Oxidative Stress (OS) ................................ 6

2.2

Nanoparticles in biological systems ........................................................................... 7

2.2.1

Introduction to Nanomaterials............................................................................ 8

2.2.2

Cell and Nanoparticle interactions ..................................................................... 9

2.2.3

Active and Passive nanoparticles ...................................................................... 10

2.3

High Z radiation therapy........................................................................................... 11

2.3.1

Radiosensitisers ................................................................................................. 11

2.3.2

Mechanism ......................................................................................................... 13

2.3.3

Gold nanoparticles............................................................................................ 15

2.3.4

Platinum nanoparticles ...................................................................................... 17

2.3.5

Nanoceramics and Tantalum Pentoxide ............................................................ 18

2.4

Bismuth oxide and bismuth based compounds. ........................................................ 20

2.4.1

Bismuth .............................................................................................................. 20

2.4.2

Current applications for Bismuth (III) oxide and other Bismuth compounds ... 21

2.4.3

Proposed application as a high Z radiation enhancer ...................................... 22

3. Experimental Procedures..................................................................................................... 24
3.1

Synthesis .................................................................................................................... 24

3.2

Materials Characterisation ....................................................................................... 25
v

3.2.1 Thermogravimetric analysis / Differential Scanning Calorimetry (TGA/DSC) ..... 25
3.2.2

X-ray Diffraction (XRD) .................................................................................... 26

3.2.3

Transmission Electron Microscopy (TEM) ........................................................ 27

3.2.4

UV-vis Spectroscopy (UV-vis) ........................................................................... 28

3.2.5

Methylene Blue Surface area ............................................................................ 30

3.2.6

X-ray Photoelectron Spectroscopy .................................................................... 31

3.2.7

Energy Dispersive Spectroscopy........................................................................ 33

3.3

4.

Biological Characterisation ..................................................................................... 35

3.3.1

Cell splitting and counting procedure .............................................................. 35

3.3.2

NP suspension preparation ............................................................................... 37

3.3.3

Media preparation ............................................................................................. 37

3.3.4

Plating Procedure .............................................................................................. 37

3.3.5

Fixing and Staining ............................................................................................ 38

3.3.6

Cell counting and Analysis ................................................................................ 39

3.3.7

24 Hour cytotoxicity ........................................................................................... 39

3.3.8

Concentration cytotoxicity ................................................................................ 40

3.3.9

Time assay.......................................................................................................... 40

3.3.10

Reactive Oxygen Species Detection Assay and Cell internalisation ................ 40

3.3.11

Clonogenic radiation survival curves ............................................................ 41

3.3.12

Statistical Analysis ......................................................................................... 42

Results .............................................................................................................................. 44
4.1

Materials Characterisation ...................................................................................... 44

4.1.1

Thermogravimetric Analysis/Differential Scanning Calorimetry ...................... 44

4.1.2

X-Ray Diffraction .............................................................................................. 46

4.1.3

Transmission Electron Microscopy ................................................................... 47

4.1.4

UV-vis Spectroscopy .......................................................................................... 48

4.1.5

Methylene Blue Surface Area............................................................................. 49

4.1.6

X-ray Photoelectron Spectroscopy ................................................................... 50

4.1.7

Energy Dispersion Spectroscopy ....................................................................... 51

4.2

Biochemical Characterisation .................................................................................. 53

4.2.1

24Hr Cytotoxic Clonogenic assay ..................................................................... 53

4.2.2

Concentrations assay ......................................................................................... 54

4.2.3

Time exposure assay .......................................................................................... 56
vi

5.

4.2.4

Cell internalisation ............................................................................................ 58

4.2.5

Reactive Oxygen Species Assay ........................................................................ 59

4.2.6

Radiation experiments ....................................................................................... 60

4.2.6.1

125 kilovolt survival curves............................................................................ 61

4.2.6.2

10 Megavolt survival curves .......................................................................... 62

Discussion ........................................................................................................................ 63
5.1

Material tailoring ...................................................................................................... 63

5.1.1

Synthesis and Annealing .................................................................................... 63

5.1.2

Nanoceramic aggregation and characterisation .............................................. 63

5.1.3

Oxygen Concentration ....................................................................................... 65

5.2

Biochemical behaviour .............................................................................................. 66

5.2.1

General Cytotoxicity and ROS ........................................................................... 66

5.2.2

Nanoceramic Concentration .............................................................................. 67

5.2.3

Exposure time..................................................................................................... 67

5.3

Radiation enhancement ............................................................................................. 68

5.3.1

125 kVp Survival Curves .................................................................................... 68

5.3.2

10 MV survival curves ....................................................................................... 70

5.3.3

Chemical tailoring of nanomaterial radiosensitisers ........................................ 70

5.4

Proposed future research .......................................................................................... 71

6. Conclusions: ........................................................................................................................ 73
Appendix A

kVp filter determination ................................................................................ 74

Appendix B

Nanoceramic internalisation and ROS fluorescence data ............................ 76

References: ............................................................................................................................... 80

vii

LIST OF FIGURES
Figure 2.1: Illustration of SSBs and DSBs in DNA caused by radiation .................................. 4
Figure 2.2: The general cell cycle for all living cells. ............................................................... 6
Figure 2.3: Dimensionality classifications of nanomaterials. ................................................... 8
Figure 2.4: Illustration of surface area vs. particle size .......................................................... 9
Figure 2.5: Cellular internalisation schematic for nanoparticles ........................................... 10
Figure 2.6: Enhanced radiation mechanism with presence of radiosensitiser nanoparticles.
.......................................................................................................................................... 13
Figure 2.7: Electron production under radiation as a function of incident photon energy .... 15
Figure 2.8: Graph of mice survival after various treatments of subcutaneous EMT-6 tumours.
.......................................................................................................................................... 16
Figure 2.9: Double and single strand breakages of Platinum NP, platinum chloro terpyridine
(PtTC), and Pt NPs with dimethyl sulfoxide (DMSO). .................................................... 18
Figure 2.10: Cell survival curves for 9L cell cultures irradiated with 10MV X-rays showing
the dose-modifying response of tantalum pentoxide nano structured particles (NSP) .... 19
Figure 2.11: Slow control cooled Bismuth metal crystal. ....................................................... 20
Figure 3.1: DSC/TGA schematic ............................................................................................. 25
Figure 3.2: X-ray beam path through a crystal. ...................................................................... 26
Figure 3.3: Transmission Electron Microscope schematic ..................................................... 28
Figure 3.4: General schematic of a UV-vis spectrometer ....................................................... 29
Figure 3.5: Example band gap determination plot .................................................................. 30
Figure 3.6: A) general XPS schematic and B) example XPS spectrum. .................................. 32
Figure 3.7: Simple schematic of the EDS mechanism ............................................................. 34
Figure 3.8: A typical haemocytometer..................................................................................... 36
Figure 3.9: Counting chamber ................................................................................................ 36
Figure 3.10: P value explanation ............................................................................................ 42
Figure 4.1: DSC/TGA of Bi2O3 precursor under different atmospheres ................................. 44
Figure 4.2: XRD spectra of Air and Argon annealed Bi2O3 NPs. Inset: a typical NP
agglomerate TEM. ........................................................................................................... 46
Figure 4.3: HR-TEM image of Bi2O3 nanoceramic platelets. ................................................. 47
Figure 4.4: Absorption Spectra of Bi2O3 nanoceramics. ......................................................... 48
Figure 4.5: Langmuir plot of Bi2O3 nanoceramics for determination of surface area ........... 49
viii

Figure 4.6: XPS spectrum for Bi2O3 in regions for A) 1s oxygen and b) 4f and 5d bismuth. . 50
Figure 4.7: A) EDS surface and B) secondary radiation spectrum. ........................................ 52
Figure 4.8: 24 hours Cytotoxicity assay for 9L and MDCK cells at 50µg/mL........................ 53
Figure 4.9: The effects of nanoparticle concentration on 9L cell survivability. ..................... 55
Figure 4.10: Concentration based cytotoxicity of argon and air annealed Bi2O3
nanoceramics on MDCK cells. ....................................................................................... 56
Figure 4.11:24, 48 and 72 hour exposure time assay of nanoceramics on 9L cells at
50µg/mL. .......................................................................................................................... 57
Figure 4.12: 24, 48 and 72 hour exposure time assay of nanoceramics on MDCK cells. ...... 58
Figure 4.13: ROS levels for Bi2O3 nanoceramics at 2Hr and 24Hr time intervals. ................ 60
Figure 4.14: Survival curves of 9L cells treated with argon and air annealed Bi2O3
nanoceramics under 125 kVp x-ray radiation. ................................................................ 61
Figure 4.15: 10 MV survival curve for 9L cells with argon annealed Bi2O3. ......................... 62
Figure A1: Ratio of mass energy coefficient of Bi2O3 relative to water .................................. 74
Figure A2: The output spectrum emitted from the orthovoltage X-ray unit at 125 kVp (filter 4)
at the POWH .................................................................................................................... 75
Figure A3: Output spectrum emitted from the "Bondi" linear accelerator unit at 10 MV at the
POWH .............................................................................................................................. 75
Figure B1: 9L internalisation plots ......................................................................................... 77
Figure B2: MDCK internalisation plots .................................................................................. 77
Figure B3: 9L fluorescence plots ............................................................................................. 78
Figure B4: MDCK fluorescence plots ..................................................................................... 79

ix

LIST OF TABLES
Table 2.1: Radical and non-radical oxygen based species generated in biological processes 7
Table 4.1: Atomic composition of nanoceramics from X-ray photoelectron spectroscopy ----51
Table 4.2: Atomic concentration of Bismuth oxide nanoceramics determined by EDS --------51
Table 4.3: Mean SSC values for 9L and MDCK cells at 2 and 24 hours. ------------------------59
Table 4.4: α and β co-efficients and SER for control & Bi2O3 curves from quadratic
exponential equation -------------------------------------------------------------------------------61
Table 4.5: α and β co-efficients and SER for control & Bi2O3 curves from quadratic
exponential equation -------------------------------------------------------------------------------62
Table B1: Flow Cytometer settings --------------------------------------------------------------------76

x

LIST OF ABBREVIATIONS

NP(s)

Nanoparticle(s)

TEM

Transmission Electron Microscopy

SEM

Scanning Electron Microscopy

XRD

X-ray Diffraction

TGA

Thermogravimetric Analysis

DSC

Differential Scanning Calorimetry

XPS

X-ray Photoelectron Spectroscopy

EDX/EDS

Energy Dispersive X-ray Spectroscopy

RT

Radiation Therapy

LET

Linear Energy Transfer

DNA

Deoxyribonucleic Acid

SSB

Single Strand Breaks

DSB

Double Strand Breaks

OS

Oxidative Stress

ROS

Reactive Oxygen Species

DPBS

Dulbecco’s Phosphate Buffered Saline

DMEM

Dulbecco’s Modified Eagle Media

HBSS

Hank’s Balanced Saline Solution

FBS

Foetal Bovine Serum

SER

Sensitisation Enhancement Ratio

9L

9L Gliosarcoma Rat tumour cells

MDCK

Madin Darby Canine Kidney cells

IHMRI

Illawarra Health and Medical Research Institute

ISEM

Institute of Superconducting and Electrical
Materials

xi

1. Project Aims and Objectives
In this thesis we will investigate the biochemical tailoring and dose enhancement
properties of Bismuth oxide nanoceramics. In doing so we will fulfil the following objectives:



To develop and synthesise Bismuth oxide with oxygen deficiency and compare to
fully oxygenated Bismuth oxide.



To examine the biochemical activity between the two materials in cancerous 9L
Gliosarcoma rat tumour and non-cancerous Madin-Darby canine kidney cell cultures.



To investigate the radiation enhancement activity of the tailored nanoceramic in
highly radio resistant 9L Gliosarcoma cancer tumour cells under megavolt (MV) and
kilovolt (kV) radiation.

1

2. Literature review

2.1

Radiation therapy

Radiation therapy is a common treatment for many cancers and has been used
extensively for many years. The treatment involves the use of high energy radiation, usually
X-rays, to target an area of cancerous tissue and expose it to ionising radiation inducing
apoptosis of cancerous tissues

(1)

. It is often combined with surgery and chemotherapy in

order to maximise the effectiveness of the treatment. In Australia, cancer remains one of the
most prevalent diseases with over 124,000 diagnosed in 2013 and is responsible for over 30%
of deaths per annum (2).

2.1.1

History

The history of radiation therapy began over 100 years ago with the discovery of Xrays. The advancement of treatments has often been connected to the development of new
technologies, with greater capacities than previous generations, and improved knowledge of
cancers. Radiation therapy (RT) was first proposed in the late 1890’s after the discovery of
X-rays and within 3 years it was used to treat cancer (3,4). The first published use of radiation
to treat the disease was made by Victor Despeignes several months after the discovery of Xrays (4,5) but the first ever use is credited to Emil Grubbé, a medical student and manufacturer
of incandescent lamps, through a retrospective study published in 1933 (5,6). Many of the early
treatments were large single doses lasting up to 1 hour with severe side effects

(4)

and large

amounts of damage to non-malignant tissue. The early years of the 1900’s were focussed on
the development of treatments, with fractional radiotherapy proposed in 1911

(7)

but not

confirmed until the 1920’s when it formed the basis of external beam radiotherapy (XRT).
This was made possible with the development of 200 kVp “hot” cathode x-ray tubes by
General Electric. Treatment schedules were widely varied throughout the 1930-1940’s,
however the development of time-dose relationships and the Nominal Standard Dose formula
cemented the use of XRT over radium therapy, as it took into account the total dose, number
of fractions, and overall treatment time. This was also aided by the production of the more
powerful “cascade” cathode x-ray tube capable of producing 700 kVp X-rays.
2

The clinical use of 6 MV linear accelerators (LINAC) commenced during 1956, and
during the 1960 -1980’s radiation therapy became one of the primary methods for treating
cancer. This was due to the increasing availability of compact linear accelerators, computer
planning, and the development of other imaging techniques

(8)

. The radiation area produced

by the linear accelerators was able to be shaped according to the specific location of the
tumours through the use of metal plates, now replaced by multileaf collimators

(9)

. This

reduced the unwanted radiation damage to non-malignant cells leading to the technique
known as 3D conformational radiotherapy.
Advancements in computer planning technology allowed the realisation of intensity
modulated radiation therapy (IMRT) in late 1990. First proposed years earlier, IMRT has
now become the standard treatment for cancer sufferers, and is often coupled with
chemotherapy (4,10). Currently there are many different fields of research being investigated to
further enhance the effectiveness of this powerful technique. One of these is the development
of newer treatment plans based on virtual patients, created through the use of computed
tomography (CT) and dosimetry. The patient undergoes imaging using one or more
techniques such as MRI. The information is then compiled to form a virtual patient and a
radiation treatment is calculated to optimise the dose and configuration using dosimetry
techniques

(11)

. A more recent advancement for radiotherapy is the investigation into

therapeutic particle beams, namely protons. This has proven to be effective in treating
delicately located tumours, but it is expensive and there are a limited number of facilities
(6,10,12)

. Finally, radioprotectors and radiosensitisers

(13)

have made consistent progress over

the last decade with the introduction of nanoparticles (as discussed in section 2.3).

2.1.2

Damage Mechanisms

The radiation used to kill cancerous cells induces apoptosis by irreversibly damaging
the DNA in the cell’s nucleus. This occurs via single and double strand breakages which
prevent the DNA from functioning correctly and causes the cell to die. This DNA damage is
performed through two mechanisms – direct and indirect damage – the amount of which is
determined by the linear energy transfer (LET) of the incident radiation. Linear energy
transfer is a measurement of the energy deposition by local interactions originating from the
incident radiation photons

(14)

. The depth of therapeutic radiation penetration increases

proportionally to the energy but the amount of energy imparted on cells by the radiation
3

decreases. The lower energy / higher LET radiation treatments using kilovolt instruments
have a broader radiation spectrum which penetrate less, but impart more energy into the cells.
These are used for superficial cancers which cannot be removed surgically, e.g. skin cancers.
The higher energy (lower LET) megavolt linear accelerator instruments are used for deeper
internal cancers, e.g. bowel, liver and lung, where greater penetration depth is required.
The direct damage mechanism describes the breakage of DNA in the nucleus through
direct interaction with therapeutic radiation. This results in bond breaking between the base
pairs of the DNA (Adenine, Thymine, Cytosine and Guanine) as the ionised base pairs no
longer interact in the correct fashion, preventing normal functionality. As the cancerous cell
attempts mitosis with the broken DNA strands the apoptosis sequence is activated resulting in
cell death. The two types of DNA breakages which occur from exposure to ionising radiation
are single strand breaks (SSB) and double strand breaks (DSB). These aptly describe the
nature of the breakages with single strand breakages causing disconnections in one strand of
the double helix, while double breakages cause disconnections between both strands at the
same location. Single strand breakages occur more commonly with low LET radiation such
as high energy X-rays or gamma rays, and are less damaging as the cell can repair the single
strand through the use of repair enzymes

(15)

. High LET radiation is linked to a higher

generation of DSBs due to the clustering of damage from low energy electrons. These
breakages are more permanent than SSBs and result in higher rates of cell death.

Figure 2.1: Illustration of DSBs and SSBs in DNA caused by radiation (16)

4

Indirect damage occurs when the DNA of the cell is not damaged by the secondary
electrons generated by the ionising radiation but by the production of free radicals. These
radicals interfere with the nucleotide binding through reactions with the base pair sequence,
preventing DNA transcription and cellular mitosis. There are many radical products
generated under radiation conditions but the most common radicals examined for cancer
treatments are reactive oxygen species (ROS). Via the process of radiolysis, an electron is
released from a water molecule after interaction with the ionising radiation causing the water
molecule to split into HO· or H· radicals. The newly formed radicals immediately react with
nearby proteins (17), water or DNA causing a cascade of radical reactions which are unable to
be regulated by the cell’s own antioxidant countermeasures. This ultimately results in the cell
undergoing ROS mediated apoptosis. This form of indirect damage was shown to be more
common than direct damage in the treatment of cancer (18).

2.1.3

Cellular response to Radiotherapy

Originating shortly after the discovery of X-rays and their implementation in the
treatment of diseases, radiobiology studies the effects of ionising radiation on living tissues,
primarily cells. It measures the many factors of the impact of radiation on both cancerous and
non-cancerous cells including vascularity (the ability to obtain nutrients), reproductive nature
and sensitivity to radiation

(19)

. Cancerous cells have faulty apoptosis genes which causes

them to grow continuously and invade other organs by developing vascularisation. However,
cancerous cells do not demonstrate the differentiation present in other types of cell, making
them more susceptible to radiation therapy. The radiosensitivity of cancerous cells is
determined by two main factors: the stage in the cell cycle and the internal pH. The stages of
cellular activity, ranging from growth to mitosis, are described in the cell cycle. Cells are
shown to vary in sensitivity depending on their stage of development, with low sensitivity
during the S phase but higher sensitivity during the G2 and M phases where the chromosomes
are exposed (figure 2.2)

(20,21)

. Some cancerous cells have developed a countermeasure for

radiation therapy by becoming hypoxic, e.g. sarcoma and glioma cancers

(22)

. The hypoxic

environment has low levels of oxygen and requires high amounts of radiation to treat the
tumours effectively. The presence of oxygen in cells will permanently set the damage done
by radiation-induced free radicals. Therefore, cancers with low levels of oxygen have an
increased recovery rate from free radical based damage.
5

Figure 2.2: The general cell cycle for all living cells. Source:
http://www.bdbiosciences.com/wcmimages/apoptosis_analysis_cellcycle_phases_lrg.jpg

Cancerous cells are able to correct the damage done to DNA through the use of
special repair enzymes similar to those involved in mitosis. However not all damage can be
corrected or compensated for by the cells, leading to cell apoptosis. There are three scenarios
for DNA damage after radiation therapy: 1) there is too much damage to the DNA and the
cell undergoes apoptosis; 2) DNA damage is repaired and the cell recovers or; 3) the DNA is
mutated which is passed on to daughter cells. These are dependent upon the cell’s stage in the
cell cycle and the presence of p53 enzyme (6). Excessive DNA damage will trigger cell death
independent of the cell cycle as the DNA cannot be repaired or used for transcription. The
p53 enzyme is one of the proteins responsible for delaying the cell cycle after radiation,
allowing the cell to correct DNA damage. If p53 functionality remains in the cell then the
damage will be repaired and the cell recovers, however, if it is lost through protein mutation
then the cell continues with the replication of compromised DNA. This eventuates in the
death of the daughter cells.

2.1.4

Reactive Oxygen Species (ROS) and Oxidative Stress (OS)

All living cells have naturally occurring levels of reactive oxygen species (ROS) as
part of their regular metabolic activity. These are generated during mitochondrial production
of ATP and the reduction of O2 into water through the electron transport chain

(23)

. This

process is highly efficient, however, the superoxide radicals (O2-•) can leak into the
cytoplasm, resulting in the production of hydrogen peroxide (H2O2). Due to this occurrence,
6

there are a series of catalase and dismutase enzymes designed to convert the ROS (such as
peroxide and superoxide) back into safer compounds and eventually H2O. When the levels of
ROS in a biological system are elevated, the system is said to be under oxidative stress (OS),
a condition associated with a variety of health problems from cardiovascular disease and
heart ventricle degradation

(24)

to premature ageing

(25)

. Oxidative stress is also connected

with enzyme deficiencies linked to neurological diseases, like Parkinson’s

(26)

and

Alzheimer’s (27), and it can cause insulin resistance and hyperglycaemia in diabetes sufferers
(28,29)

. On the cellular level, oxidative stress has the potential to fragment and degrade proteins

(25,30,31)

and damage lipid membranes (32).

Table 2.1: Radical and non-radical oxygen based species generated in biological processes (33)

Name

Symbol

Oxygen (Bi-radical)

O2..

Superoxide Ion

O2.-

Hydroxyl

HO.

Peroxyl

ROO.

Alkoxyl

RO.

Nitric oxide

NO.

Non-radical Oxygen

Hydrogen peroxide

H2O2

derivatives

Organic peroxides

ROOH

Hypochlorous acid

HOCl

Ozone

O3

Aldehydes

HCOR

Singlet oxygen

1

Peroxynitrite

ONOOH

Oxygen Radicals

2.2

O2

Nanoparticles in biological systems

Nanomaterials have various applications across all fields of science and engineering,
including biological fields. The interactions with biological and cellular environments depend
on the morphology and the surface charge of the nanomaterial system. Many functional
nanomaterials are toxic to biological systems due to the incorporation of reactive
components. To counter the toxicity, while retaining the desired functionality, these
7

nanomaterials undergo surface modification with biocompatible compounds forming
core/shell systems.

2.2.1

Introduction to Nanomaterials

Nanomaterials are defined as a material having at least one dimension under 100nm.
They are further classified by dimensionality which refers to the number of nanoscale
dimensions, defining a nanomaterial as 3-, 2-, 1- or 0-d. Materials with all dimensions on the
nanoscale, i.e. single isolated particles in suspensions, are classified as 0d. 1d nanomaterials
are those with two dimensions in the nanoscale, e.g. nanorods, 2d are those like thin films or
nanoplatelets of only nanometre thicknesses, and 3d nanostructures are fibrous, multilayer
and polycrystalline materials or powders in which the 0d, 1d and 2d elements are in close
contact forming interfaces (34).

Figure 2.3: Dimensionality classifications of nanomaterials. Source:
http://eng.thesaurus.rusnano.com/upload/iblock/dfc/nanomaterial1.jpg

All nanomaterials have a large surface area which allows for the unique properties not
found in their bulk counterparts, such as high conductivity, unique optical properties, and
catalytic activity. This is a result of a high surface to volume ratio

(35)

, the amount of surface

molecules to internal molecules, and the correlating increased surface energy. The surface of
the bulk material is considered to be a “defect” in the material lattice, with the surface atoms
having higher energies than the internal bulk layers due to unsatisfied or non-coordination
bond exposure to the surface

(36)

. Simply put, this means that the atoms on the surface of

nanomaterials have higher energies because they form bonds with non-lattice molecules.
Due to the size parameters of nanomaterials, the vast majority of the atoms in the
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nanoparticles are surface “defect” atoms providing the high energy surface responsible for the
unique properties found only in the nanomaterial.

Figure 2.4: An illustration of nanoparticle surface area in relation to particle diameter (24)

The fundamental differences in these nanomaterials allow their application across all
fields of science and engineering, examples being carbon nanotubes, graphene, silica
nanoparticles and gold nanoparticles. Much of the focus of nanomaterial research has been in
the development of new technologies such as graphene for supercapacitor technology

(37, 38)

.

Some biomedical applications for these nanomaterials include gold nanoparticle and silica
quantum dot imaging agents

(39-42)

, drug delivery systems

(43,44)

, “lab on a chip” devices, and

radiosensitisers for cancer therapy (Section 2.3).

2.2.2

Cell and Nanoparticle interactions

Nanoparticle interaction with living cells depends on a variety of factors including
nanoparticle surface properties, shape, size and the type of cells. While there are many unique
mechanisms for individual cell/ NP combinations, the general process is well known to be
based on surface charge interactions between the cell membrane and the nanoparticle.
Nanoparticles interact with cell membranes through the process of endocytosis

(45)

. They are

actively transported into the cell by encapsulating the NP in a vesicle, and then internalised
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through the membrane’s natural procedures, depending on surface charge and particle size. It
has been shown that certain nanoparticles with a negative surface charge had greater
internalisation than their positive counterparts (46,47). It was also shown that nanoparticles with
sizes below 50 nm had the best internalisation

(40,48)

. Nanoparticles can also be transported

using passive diffusion if they are only a few nm in diameter or if the particular cell lacks the
endocytosis mechanisms e.g. red blood cells (40). Unlike normal phagocytosis, the internalised
nanoparticles can be found throughout the cell and can induce cytotoxic effects based on size,
e.g. 1 – 2 nm particles inhibiting DNA replication in the nucleus.

Figure 2.5: Cellular internalisation schematic for nanoparticles

2.2.3

Active and Passive nanoparticles

Nanomaterials with biological applications can be classified into two general
categories defined by their activity under non-radiation conditions in vitro

(49)

. The first are

“active” nanomaterials which induce either cytotoxic or growth enhancing effects in cells.
The majority of these materials have reactive components which provide the desired
functionality but kill cells indiscriminately when introduced into a biological environment.
This occurs through either inhibiting cellular metabolism or the generation of toxic or radical
compounds. Due to this occurrence, a number of countermeasures have been developed to
provide biological passivity via surface modification. This involves coating the surface of the
nanomaterial or nanoparticle with a biologically safe compound forming core-shell
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nanoparticles. The most commonly used modifiers are polymers/biopolymers or biologically
inert inorganic compounds e.g. polyethylene glycol (PEG), amino acids, silica and gold (50,51).
An excellent example of an “active” nanomaterial is cerium dioxide with its reversible 3+/4+
redox activity (52).
The second type of nanomaterials are those classified as “passive”. These materials
are chemically inert and highly biocompatible, with any toxicity being directly related to the
quantity of material introduced to the biological environment (concentration-toxicity
relationship). This type of nanomaterial is the most common in radiosensitisation research
with two examples being the well-known gold (section 2.3.3) and tantalum pentoxide (section
2.3.5).

2.3

High Z radiation therapy

The idea of using chemical agents to increase the effectiveness of radiation therapy
was proposed soon after the application of X-rays in cancer treatment. Testing found that
chemical compounds with high Z elements (where Z = atomic number) were best suited as
the radiation triggered the release of electrons from the high Z elements. The first high Z
nanoparticles to be investigated were gold NPs and research progressed to platinum and high
Z nanoceramics. The effectiveness of the nano radiosensitisers are commonly defined by
three different terms: dose enhancement ratio (DER), dose enhancement factor (DEF) and
sensitisation enhancement ratio (SER). They all quantify the gain, or the biological
consequences of the gain, in energy deposited due to the introduction of the high Z compound
compared to an untreated control. While DEF or DER are usually a purely physical quantity,
calculated as the ratio between the dose in untreated control versus the sample treated with
the high Z element, the SER is extracted from the experimental data being the ratio of
physical doses necessary to get a specific radiobiological endpoint, e.g. 10% clonogenic cell
survival fraction (53).

2.3.1

Radiosensitisers

There has been much research into improving the effectiveness of radiotherapy while
reducing the unwanted side effects caused by damaging non-cancerous tissue. This arises
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from the unspecific nature of RT and development of deeper seeded tumours

(54)

. Initially

chemical compounds were investigated for their radiation enhancing properties, finding that
compounds with atomic high Z elements were the most effective as they enhanced radiation
damage through the release of secondary electrons. These agents were injected into the
patient at the tumour site and entered the nucleus of the cell destabilising the DNA peptide
bonds. The destabilised DNA became more sensitive to radiation damage hence the name
radiosensitisers. The examination and development of chemical radiosensitisers is still
ongoing with platinum based compounds, such as cisplatin

(55,56)

, and other high Z elements

(57)

.
Once nanoparticles had been established in the medical field, research interest

diversified to the use of metal nanoparticles as individual radiosensitising agents or in
combination with chemical agents. Investigations into gold NPs

(58)

and other metals with

current medical application were performed as it was essential that the nanomaterials used
were biocompatible. The research diverged into two regions after experiencing problems with
concentration-based toxicity for the pure heavy metal nanoparticles. The first direction was
surface modification of metal NPs with biological and synthetic polymers, e.g. proteins or
polyethylene glycol (PEG), while the second was to investigate the use of high Z metal oxide
NPs (nanoceramics)

(59)

. There are two advantages of using nanoceramics over surface

modified metal nanoparticles.
Firstly, the surface modifier of a coated nanoparticle or nanoparticle system may
shield the radiosensitiser from the incident radiation thereby reducing its efficiency. This
does not occur in nanoceramics.
Secondly, due to their comparatively larger size, nanoceramic particles stay within the
cell once internalised while the small metal NPs move through cell membranes with relative
ease, depending on size and surface modification (60, 61).
Nanoparticle sensitisation agents have a different sensitisation mechanism (section
2.2.2) to the chemical agents. Instead of destabilising the DNA peptide bonds to make the cell
more susceptible to radiation damage, the nanoparticles magnify the damage done to the
tumour through the production of secondary radiation and free electrons. These can damage
the DNA directly if located close to the nucleus or generate copious amounts of ROS which
in turn damage the cell.
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2.3.2

Mechanism

Nanoparticle radiosensitisers have a different physical mechanism compared to the
previous generation of chemical sensitisers. For patients requiring both radiation and
chemotherapy, initial chemical radiosensitisers were compounds designed to enter the
nucleus of the cancerous cells and have a variety of effects, from binding to or replacing
DNA base pairs to inhibiting particular cellular processes. The DNA becomes destabilised
and more susceptible to radiation damage which results in higher tumour death rates. The
approach for using nanoparticles as radiosensitisers is different. The incident photon beam
directly interacts with the nanoparticles through physical interactions during the radiation
treatment, amplifying the effects through secondary radiation, electron production and
generation of reactive oxygen species (ROS). The therapeutic beam interacts with the high Z
elements triggering the release of photo-, Compton-, and auger electrons, which are propelled
away from the sensitiser. These free electrons interact with either the DNA, if the sensitiser
is in close proximity

(54)

, or the surrounding environment, to generate various ROS which

inflict indirect damage to the DNA and the cell (ROS induced apoptosis)

(62)

. The high

energies of the therapeutic beams also cause the NPs to become radiocatalysts (63) which will
generate ROS in addition to the radiolysis.

Figure 2.6: Enhanced radiation mechanism with presence of radiosensitiser nanoparticles.
Source: http://www.mpsd.de/irt/IRT.html and modified 8/8/13
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The type and quantity of electrons produced has been studied extensively and was
found to be dependent on the energy of the therapeutic radiation. The four types of electrons
produced during radiation therapy are photoelectrons, Compton, Auger and electron-positron
pair.
The photoelectric effect is the most probable form of photon interaction with high Z
materials for kilovoltage treatments. Photoelectrons are produced through the complete
absorption of the incident photon energy by an atom, leading to the ejection of an inner shell
electron

(64,65)

. Immediately after the release of an electron from an inner atomic shell, the

excited atom will reorganise itself by transferring an electron from an outer shell to the inner
shell. The release of the electron’s potential energy during this transfer produces fluorescence
and Auger electron cascades (66).
The Compton effect is largely predominant in the megavoltage range for most
materials and is a process where the high energy photon loses its energy through multiple
inelastic collisions with outer shell electrons. The incident photon collides with and imparts
kinetic energy to the electron, ejecting it from outer atomic orbitals

(64,65,67)

. These high

energy electrons are referred to as Compton electrons.
Electron - Positron pair production only happens for photons of at least 1.022 MeV.
Pair production occurs under high energy radiation through the interactions between the
incident photons and the nucleus. The energy of the photon is then converted into the rest
mass of the matter- antimatter pair (electron and positron) with excess kinetic energy (if E >
1.022MeV) according to the conservation of momentum (68,69).
During the treatment of superficial cancers with the kilovoltage instrument, the main
electrons produced are photo- and Compton electrons while during treatment with the
megavoltage linear accelerators electron-position pair production and Compton effect occur
preferentially.
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Figure 2.7: Contribution of the different types of physical interactions on the total mass absorption coefficient
for bismuth material as a function of incident photon energy.
Source: personal communication with Dr Stéphanie Corde.

Electrons of a given atomic shell can be ejected if the incident photon energy is higher than
the binding energy of the electron considered (appendix A).
In the kilovoltage range, the demonstrated dose enhancement is mainly due to photoelectric interactions whose interaction cross sections are highly Z dependant (Z3-4). Compton
scattering is a photon-atomic electron interaction which is mainly independent to Z, whereas
pair production occurs primarily by interaction with the atomic nuclei and is proportional
to Z2. Above 5 MeV, pair production becomes dominant if high-Z materials are present (59,69).
High Z elements are ideal as radiosensitisers as they increase the probability of interaction
between the photon and the material, therefore increasing the generation of potentially
damaging secondary electrons in the cellular environment.

2.3.3

Gold nanoparticles

The first high Z nanoparticles to be investigated for radiosensitising properties were
gold nanoparticles (Au NPs), published in 2004

(58)

. Mice were injected with EMT-6

mammary carcinomas and intravenously given a dose of 1.9±0.1 nm gold NP at 1.35 mg Au /
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g and 2.7 mg Au / g of mouse weight. After two minutes the tumour sites were irradiated with
250 kVp X-rays. An examination of the tumours one month after irradiation showed that
mice receiving radiation without Au NPs had tumours five times the volume of those
receiving both NP and radiation, while the mice not receiving radiation showed no difference
between the NP and non-NP groups (58). The survival of the mice post treatment was observed
over a year and the survival fractions are shown below (figure 2.8).

Figure 2.8: Graph of mice survival after various treatments of subcutaneous EMT-6 tumours. ●: gold only (1.35
g Au/kg), ▲: irradiation only (26 Gy, 250 kVp), ▀: irradiation after i.v. injection of 1.35 g Au/kg gold
nanoparticles, ♦: irradiation after an injection of 2.7 g Au/kg. (58.)

Multiple studies were performed to investigate the cytotoxicity of Au NP in vivo and
in vitro with the intention of use as radiosensitisation agents, but have been performed with
some conflicting data. Since bulk gold is biocompatible it was proposed that the nanoparticles
would maintain this, however, due to the large variety in size and morphology of the
nanoparticles investigation was needed. For sizes below 5 nm it was suggested that the
electronegativity of the Au NPs will cause them to penetrate the nucleus and bind directly to
the DNA, resulting in highly toxic effects
by Y. Pan et al

(71)

(70)

. The cytotoxic size dependency was confirmed

who studied the effect of Au NPs ranging from 0.8 – 15 nm in four cell

lines and showed that gold nanoparticles with diameters of 1-2 nm were highly toxic and
induced apoptosis and necrosis, while the large particles of 15nm were nontoxic. These
effects were also shown to be independent of the cell line. A study was also performed by
Sun et al

(72)

to examine the effects of particle morphology on cytotoxicity in Chinese Kun
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Ming (KM) mice which showed that Au nanorods were the most toxic, followed by cubes
with the most biocompatible being nanospheres.
After the article published by Hainfeld et al

(58)

there have been thorough

investigations using different cell lines, nanoparticle sizes and radiation energies to determine
the effectiveness of gold nanoparticles. Zhang et al

(73)

showed that gold NPs coated in

polyethylene glycol (PEG) had a 5 Gy dose enhancement that was dependent on the size of
the nanoparticles. In a study done by Rahman et al (74) it was shown that 1.9 nm spherical Au
NPs had a dose enhancement that is dependent on NP concentration. Another study
performed by Rahman et al (75) demonstrated that the 1.9 nm Au NP dose enhancement effect
is energy dependent. Butterworth et al

(76)

showed at 100 µg/mL the effectiveness of the 1.9

nm Au NPs under radiation is highly dependent upon the type of cell line being examined,
with DEF results ranging from 0.81 to 1.97. This confirmed the work previously done in the
field illustrating the need for nanoparticle optimisation. The radiation enhancement research
being done focussed predominantly around the effectiveness of the NPs at a single dose point
and as such there was a variation in results. However, the paper published by Jain et al

(77)

examined gold spherical NPs of 1.9 nm over a range of dose points (0-6 Gy) and determined
the SER for breast cancer (MDA-MB-231), prostrate tumour (DU145) and lung epithelial
(L132) cell lines using “linear quadratic exponential model” curves. These results show a
high SER for breast cancer cells but little to no enhancement for the two more radioresistant
cancerous cells lines thus demonstrating the enhancement limitations of the gold
nanoparticles.

2.3.4

Platinum nanoparticles

After Au NP research was underway, other noble metals used in medicine were
investigated, one being platinum nanoparticles (Pt NPs). These nanoparticles have not been
examined as thoroughly as gold nanoparticles but have proven results with radiation
enhancements (78).While the research is not extensive, like the compatibility of gold NPs, in
vitro and in vivo studies have shown that platinum nanoparticles are biocompatible (79,

80, 81)

This is due to the NPs ability to scavenge reactive oxygen species on the cellular level

(82)

.

In the article published by Porcel et al (54), platinum nanoparticles were shown to be
highly effective in enhancing radiation damage. The platinum nanoparticles used were 4 -6
nm in diameter and were able to fit in the spaces between the nucleotides in the DNA.
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.

After exposure to radiation, the Pt NPs caused massive amounts of direct damage to DNA
with large DSB and SSB ratios of 1.6 – 2.2 and 1.4 – 1.6 respectively compared to the
control. The authors proposed this was due to the large number of Auger electrons that
interacted directly with the DNA due to the close proximity of the nanoparticles along with
contributions from the ROS.

Figure 2.9: Double and single strand breakages of platinum NP, platinum chloro terpyridine (PtTC), and Pt
NPs with dimethyl sulfoxide (DMSO). Source: Porcel et al (54) and modified.

These findings have been confirmed by Asharani et al

(83)

. In their article, the

platinum nanoparticles coated in PPA are shown to diffuse through the cell membrane and
bind to the structure of the DNA, causing direct damage to the DNA strands and the cellular
environment when exposed to radiation. The authors discovered that the Pt NPs caused an
increase of apoptosis through the p53 and p21 metabolic pathways and demonstrated that the
small nanoparticle size (5-8 nm) was essential for the p53 metabolic apoptosis to occur. The
larger (30 – 50 nm) particles showed impaired activity and were unable to diffuse across the
cell membrane.

2.3.5

Nanoceramics and Tantalum Pentoxide

Despite the effectiveness of the Au and Pt NPs, they were still heavy metals and
induced concentration-based cytotoxicity independent of the size of the nanoparticles

(73)

.A

method for retaining high Z functionality with biocompatibility was required and research
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shifted into nanoceramics. Nanoceramics are metal–organic compounds engineered to have
particle sizes of less than 100 nm in any one dimension through the use of nanotechnology
processes. Although multiple ceramics have been tested in the search for an effective
radiosensitiser

(84)

, tantalum pentoxide (Ta2O5) has been a stand out material for high Z

radiation enhancement cancer therapy. Tantalum is a rare earth metal with an atomic Z of 73
and in the pentoxide form has been used for medical applications such as orthopaedic surgery
(85, 86)

. The article published by Brown et al

(59)

shows the high Z tantalum pentoxide

nanoceramics had a 10 MV SER0.1 of 1.33±0.07 at 50 µg/mL on the highly radioresistant 9L
gliosarcoma cell line (figure 2.10). This is comparable to the enhancement of 1.29 obtained
with 1.9 nm gold nanoparticles used at a higher concentration, i.e. 100 µg/mL (77, 87) under 6
and 15 MV energies.

Figure 2.10: Cell survival curves for 9L cell cultures irradiated with 10MV X-rays showing the dose-modifying
response of tantalum pentoxide nano structured particles (NSP). Surviving fractions were normalized to nonirradiated control cells, averages taken from a sample size of 3 and errors given ± 1 standard deviation from
the mean. (59)

It was also shown that the Ta2O5 NPs did not have detrimental cytotoxic effects
commonly found in the higher concentrations of the pure metal nanoparticles. The
cytotoxicity of the nanoparticles remained above 80% at concentrations of 500 µg/mL due to
the chemically inert nature of the nanoceramic (59).
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2.4

Bismuth oxide and bismuth based compounds.

2.4.1

Bismuth

Bismuth is a heavy metal with a large atomic number of 83 and atomic mass of
208.98 atomic mass units (AMU). The bulk metal has a very low toxicity compared to its
neighbouring elements of antimony, polonium, and lead, which are known to be highly toxic
to biological systems. Bismuth based compounds have had many biological and nonbiological applications over the years, even being used for cosmetics (see section 2.4.2).
Bismuth is quite brittle in the metallic form making it ineffective in metallurgical applications
but it acts as additives or replacements for lead in metal alloys

(88)

with use in electronics,

catalysts, and plastics. It is also used in organic chemistry as a co-ordination and catalytic
agent (89).

Figure 2.11: Slow control cooled Bismuth metal crystal. Source: http://imgur.com/gallery/qCtmD

Bismuth (Bi) is already known to be a biocompatible metal in bulk but investigations
into the cytotoxicity of the corresponding pure metal nanoparticles have shown that this
biocompatibility does not carry over to the nanoscale. In the paper written by Luo et al (90) the
authors proved the nanoparticles of Bi(0) metal and bismuth coated with polyethylene glycol
(PEG), silica and amine groups had a negative impact on cell viability.
20

Bismuth oxide (also known as Bismite)

(88)

is one of the native forms of bismuth

metal and has a series of crystal phases: α (monoclinic), β (tetragonal), δ (cubic), γ (cubic)
and ɛ (triclinic)

(91)

. It has many applications of its own in electronic ceramics, solid state

electrolytes, photoelectric materials, superconductive materials, catalysts, cosmetics and the
medical field, but has not been examined for radiosensitisation.

2.4.2

Current applications for Bismuth (III) oxide and other Bismuth compounds

Bismuth oxide (Bi2O3) and other bismuth based compounds have many applications
as components in a myriad of materials ranging from superconductors, gas detectors and
photocatalytic agents to cosmetic and medical applications.
Type 2 superconductors use bismuth oxide as a founding component
compounds have the general formula of Bi m M n Cu p O x

(92)

. These

(93)

, and have many variations of

superconducting critical temperature (Tc) values from 80-120 K

(94)

. It was shown that by

implanting the superconductors with fluorine that it was possible to increase the Tc

(95)

and

new variations of bismuth oxide based superconductors are still being produced, such as the
new double perovskite bismuth oxide (Na0.25K0.45)(Ba1.00)3(Bi1.00)4O12 (96).
Bismuth oxide is a known semiconductor with applications in gas detectors
the article published by Periasamy et al

(97)

(97, 98)

. In

it was shown that 50nm Bi2O3 nanoparticles

combined with multi-walled carbon nanotubes (MWCNT) in a thin film formed a highly
selective peroxide (H2O2) sensor.
Bismuth oxide also functions as a photocatalyst
dependent upon the crystal phase and morphology

(99–101)

with the effectiveness

(102-104)

. As a nanoceramic, bismuth oxide

shows an enhanced capability over the bulk counterpart through large surface area to volume
ratios (SA:V) and quantum size effects (105). For these reasons, research has pushed nanoscale
bismuth oxides towards photocatalysis applications such as water purification (106).
Bismuth oxide has been used in cosmetics for hundreds of years, first in the 1400’s
because of its pale colour, and traces have been found in cosmetics from Greece and Rome.
Recently it has been included as a primary component in mineral foundations along with
another bismuth compound, bismuth oxychloride, because of its pearlescent appearance and
low cost. The use of these materials in this application shows that bismuth oxide and
oxychloride are deemed safe for external use. Bismuth oxide has also been one of the primary
components of dental cement for many years

(107)

21

. A study performed by Kim et al into the

cytotoxicity of Bi2O3 for dental cement showed that an increased concentration of bismuth
oxide had no effect on the cytotoxicity for immortalised human periodontal ligament (IPDL)
cells

(108)

. This confirms the biological compatibility of the bismuth oxide ceramics in direct

exposure to sensitive cell tissue. Bismuth salts have been used in medicine for a long time,
beginning with skin condition treatments and moving to internal applications

(109)

. Bismuth

subsalicylate is currently in use as the active compound in gastrointestinal medications and
has been shown to treat Helicobacter pylori (110).

2.4.3

Proposed application as a high Z radiation enhancer

In this thesis bismuth (III) oxide was investigated for application as a high Z
radiosensitiser for multiple reasons.
Firstly, bismuth is one of the heaviest naturally occurring elements on the periodic
table. With an atomic Z of 83 (section 2.3.1), it is heavier than any other material previously
investigated and is the logical finale of high Z radiosensitiser research without branching to
radioactive compounds.
Secondly, bismuth oxide and other bismuth-based compounds are known to be
biocompatible from their use in many medical and cosmetic applications over the years
(section 2.4.2). These compounds are chemically stable and do not decompose or release
toxic components into biological systems. Studies have shown that bismuth compounds
passed through the body with <1% of bismuth building up in tissues. This will address the
cumulative toxicity issues found in other heavy metals like gold (111).
Finally, the application of Bi2O3 as a radiation enhancer for cancer therapy is a novel
direction of research for this particular material. There has been much work done on
developing effective synthesis methods for Bi2O3 nanoparticles and a strong foundation of
biological and materials analyses to build from during this work.
The study into bismuth oxide radiosensitisers also examined the viability of
chemically tailoring radiosensitisers for different enhancement properties via oxygen
concentration. Studies into the use of ceria as a radioprotector have shown that the presence
of a reversible reactive oxygen species (ROS) system has different effects, either protecting
or sensitising. An ROS system refers to the ability of a nanoparticle to scavenge or generate
ROS such as hydroxide radicals (see table 2.1), under non-radiation conditions through
surface chemistry on the nanoparticles. This is another property of nanoparticles brought
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about by their high surface energy (see section 2.2.1). The incorporation of an ROS system
into bismuth oxide nanoceramics will create a chemically active nanoparticle that possesses
an ROS scavenging/generating capacity under non-radiation conditions, while providing
radioenhancement during treatment.
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3. Experimental Procedures

3.1

Synthesis

Bismuth oxide nanoparticles were synthesised from bismuth nitrate using the
methodology outlined in the article by M.M Patil et al (112). An amount of bismuth nitrate
(Sigma-Aldrich) (8 grams) was weighed out and dissolved in 80 mL of 70% nitric acid
(Marick). Once fully dissolved, 150 mL of 30% ammonium hydroxide (Sigma –Aldrich) was
added drop wise until a white precipitate was formed. This was then filtered out and washed
in deionised (DI) water using an Eppendorf model 5702 centrifuge at 4400 rpm, following
the washing schedule of 3 x 10 minute washes and 3 x 20 minute washes. The bismuth
hydroxide precipitate was then re-suspended in 150mL of DI water and stirred at 100˚C for
5.5 hours. The precipitate (4g) was removed again by centrifuge, washed, and then annealed
in a Labec tube furnace. The annealing procedure is outlined below:
1. Heat to 530˚C at 5˚C/min from room temperature
2. Anneal at 530˚C for 4 hours
3. Cool to room temperature
The NPs were tailored during the annealing process by altering the annealing atmosphere.
For the oxygen deficient bismuth oxide, the precursor was annealed in an inert argon
atmosphere while the oxygen sufficient bismuth oxide was annealed in air. The two
compounds had a difference in colour: the air annealed nanoceramic was a strong yellow,
whereas the argon annealed was a white/ pale yellow. They were transferred to small glass
vials and kept in a 50mL tube with Silica gel crystals to prolong the life of the materials, as
the bismuth oxide NPs degraded quicker when exposed to moisture and air.
The chemical reactions in the nanoceramic synthesis are shown below:

1) Bi(NO3)3 + HNO3

[Bi]+ + HNO3 (excess)

2) [Bi]+ + 3HNO3 + 3NH4OH

Bi(OH)3 + 3NH4NO3 + H2O

3) 2Bi(OH)3 + Heat

Bi2O3 + 3H2O
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3.2

Materials Characterisation

3.2.1 Thermogravimetric analysis / Differential Scanning Calorimetry (TGA/DSC)

The bismuth hydroxide precursor was examined using a TGA/DSC instrument
(Mettler-Toledo) to determine the optimum annealing temperature for the air and argon
atmospheres. Differential scanning calorimetry and Thermogravimetric analysis (DSC/TGA)
are two coupled thermoanalytical techniques used to measure heat flow and weight change as
a function of temperature.
As the temperature is increased, the weight change and the local temperature flow of
the crucible are measured against the reference crucible. The control data is then subtracted
from the sample data to remove the artefacts generated from the crucibles.

Figure 3.1: DSC/TGA schematic. Source: http://www.hitachi-hitecscience.com/en/products/thermal/tec_descriptions/dsc.html

The bismuth hydroxide precursor was loaded into a platinum crucible, filling
approximately two thirds, and then run using the same TGA/DSC program from 45 ˚C to 900
˚

C at the rate of 10˚/min. The precursor was examined for weight loss and endothermic

/exothermic peaks under both air and argon atmospheres. The data was normalised through
the subtraction of a blank sample with the same atmospheres. The weight loss was calculated
as a percentage of the initial precursor weight using the following equation and plotted
against the reference temperature to examine dehydration, oxygen, and other material loss.
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(1)

Where: m is the mass and mi is the initial mass of the precursor.
The exothermic and endothermic peaks were also plotted against the reference
temperature. These showed the points at which the local temperature of the sample increased,
exothermic peak, or decreased, endothermic peak, brought on by phase transitions or material
decomposition. By combining the two graphs, the ideal annealing temperature was easily
determined.

3.2.2

X-ray Diffraction (XRD)

X-ray diffraction is a fundamental and important characterisation technique used for
all materials analysis. It is the process by which X-rays of known wavelength (λ) are
elastically scattered from a crystal as if reflected from a plane, passing through points of the
crystal lattice.

Figure 12.2: X-ray beam path through a crystal. Source: http://www4.nau.edu/microanalysis/microprobesem/signal_detection.html

Using Bragg’s Law

(113)

we consider the two separate X-rays to be reflected off two

parallel planes with the first striking the top and the second striking the bottom with the net
path length being:

BD+CB = 2dsinθ
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(2)

Where θ = the angle of incident X-rays.

For many incident angles this path difference will not equal a multiple of the
wavelength resulting in destructive interference, whereas those which obey this result in
constructive interference giving the peaks on the spectrum, hence Bragg’s Law (below)

(104,

114)

.
nλ = 2dsinθ

(3)

Where n is the order of diffraction, d is the interplanar spacing and θ is the diffraction angle.

In order to determine if the two materials had transformed into the desired phases, the
Bi2O3 nanoceramics were examined using the GBC MMA X-ray diffraction instrument with
Cu Kα radiation (wavelength λ = 1.5418 Å) at ISEM. The XRD was set to 25 mA and -40 kV
and set to scan from 20° - 80° at 2.00°min-1 with a step size of 0.02°. The crystal structures of
two nanoceramics were probed and examined using the “Traces” XRD program,

(59)

then

compared to the database of XRD spectra for characterisation of the crystal phases. The
crystal size of the nanoceramics was determined using the Scherrer equation

(115)

in

conjunction with the full width at half max (FWHM) of the characteristic peaks and the
silicon standard.

(4)

Where: is the crystal size, K is a dimensionless shape factor (accepted as ≈0.93) (116), λ is the
X-ray wavelength, β is the FWHM of the peak minus the Si standard and θ is the Bragg angle
of the peak.

3.2.3

Transmission Electron Microscopy (TEM)

The TEM was used to examine the physical parameters of the nanoparticles and to
compare with the XRD analysis. Transmission electron microscopes (TEMs) are one of two
types of electron microscopes. Like scanning electron microscopes, a sample was mounted
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onto a carbon web or other lattice base and inserted into the microscope examination
chamber. The chamber was then evacuated and high energy electrons of over 100 keV were
fired through the sample. The electrons were then focussed through a series of lenses and
projected onto a fluorescent screen for imaging. TEM allows high magnifications down to a
few nanometres and can be used to image a wide range of information, from diffraction
patterns to grain boundaries, defects, and material density variation.

Figure 3.3: Transmission Electron Microscope schematic. Source:
http://www.gitam.edu/eresource/nano/nanotechnology/tem.html

The samples were dispersed in ethanol and loaded onto a carbon web for examination.
After the ethanol had evaporated, the samples were examined with a JEOL 2011 TEM
operating at 200 kV. Conventional bright field (diffraction contrast) images were captured
using a Gatan Orius CCD camera. The TEM examination was performed by Dr David
Mitchel. All TEM and energy dispersive spectroscopy (EDS) procedures were performed at
the electron microscopy centre (EMC) in the Australian Institute for Intelligent Materials
(AIIM).
3.2.4

UV-vis Spectroscopy (UV-vis)

Bi2O3 is a semiconductor and as such, the UV-vis spectra were examined to find the
absorbance peaks and the band gaps of the two nanoceramics. UV-vis spectroscopy is a
common chemical technique used for quantitative analysis of solutions. The instrument is
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regularly used to obtain the absorbance, transmission, or fluorescence spectrum of a solution
from which many parameters can be calculated, such as concentration and band gap. A
sample is placed inside the UV-vis with a reference of the solvent, mainly DI water or
ethanol, and monochromatic light is passed through. The wavelength is then cycled from the
lowest to highest of the selected range of wavelengths and the transmittance at each
wavelength recorded. The transmittance is determined by comparing the amount of light from
the sample to the reference using the equation:

(5)

Where: A is absorbance, I0 is the light intensity from the reference at any wavelength, I is the
light intensity from the sample at any wavelength, epsilon (ɛ) is the extinction coefficient, c is
the sample concentration and l is the path length in cm.

Figure 3.4: General schematic of a UV-vis spectrometer. Source:
https://www2.chemistry.msu.edu/faculty/reusch/virttxtjml/spectrpy/uv-vis/uvspec.htm accessed 3 pm 12/6/14

The argon and air annealed Bi2O3 samples were made into 0.5 mg/mL suspensions by
sonicating for 2-3 hours in an ultrasonic bath. The suspensions were examined between 200 –
800 nm using a Shimatzu 3600 NIR UV-vis Spectrophotometer (Shimadzu, Kyoto, Japan)
with 1 cm path quartz cuvettes. The optical band gap (Eg) determined using the equation:

(6)
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Where m = ½ for indirect and m=2 for direct Eg.
The absorption coefficient (α) was determined by the equation:

(7)

is the density of Bi2O3 (8.90 g.cm-1), l is path length of the cuvette

Where A is absorbance,

and c is the concentration (117 – 119).
In these calculations, m=2 as it gave a better fit for extracting the Eg. The optical band
gap can then be found by plotting (αhν) 2 against hν, and fitting a straight line to the linear
portion of this curve. The intercept of this line with the x-axis is equal to the direct optical
band gap of the particles.

Figure 3.5: Example band gap determination plot (120)

3.2.5

Methylene Blue Surface area

The surface area of the nanoceramic was measured using the older method of
Methylene blue (MB) adsorption due to the effect of the Braunauer – Emmet - Teller (BET)
preparation procedure on the Bi2O3 samples. The samples are dried under low partial pressure
of oxygen to remove the adsorbed water molecules from the surface. This strips the loosely
bound oxygen from the surface of the nanoceramic, changing the surface of the material. The
MB solution based method employs chemisorption to determine the surface area of samples
30

through the use of a compound with a known binding area. It compares the calculated
concentrations to the actual concentrations in order to determine the surface area based on the
difference in equivalent molecular area. Despite the larger size of the adsorbent compared to
BET, the methylene blue prevents the formation of multiple layers on the surface of the
materials.
Firstly, 100 mg of nanoceramic was sonicated in 50 mL DI water to break up the
aggregates and 4 mg of MB added. After mixing the suspension for 1 hour and leaving to
settle overnight, a sample was taken from the stock and diluted accordingly for UV-vis
analysis. No filtering of the sample was required as Bi2O3 does not have any overlap in the
absorbance spectrum of MB. The UV-vis absorption at 665 nm of the MB solution was
measured

against

the

calibration

curve

using

a

Shimatzu

3600

NIR

UV-vis

Spectrophotometer (Shimadzu, Kyoto, Japan) and quartz cuvettes. After the absorbance was
recorded, another 4 mg of MB was added to the stock along with 5 mL of DI and the process
repeated over 7 days. The concentrations were then converted from g/L to weight ratios of the
adsorbed MB: Bi2O3 and the added MB: Bi2O3. The ratio values were plotted against each
other to produce the Langmuir curve and the point where the curve diverges from a straight
line, which is known as the ion replacement concentration, was used to determine the specific
surface area used in the following equation (121):

(8)

Where mMB is the weight of Methylene Blue added, 319.87 is the molecular weight of
Methylene Blue, AV is Avogadro’s number (6.02*1023), AMB is the accepted surface area of a
single adsorbed Methylene Blue molecule (130Å2) and ms is the weight of the Bismuth oxide.

3.2.6

X-ray Photoelectron Spectroscopy

X-ray photoelectron spectroscopy (XPS) was

conducted to

examine the

concentrations of surface oxygen on the two nanoceramics. XPS is a technique which
quantitatively measures the elemental composition of compounds at the surface of the
material, having a penetration depth of a few nanometres. It can easily detect almost all
elements, but has difficulty with H and He, and can detect atomic concentrations up to parts
31

per thousand

(122)

. The measurements are based on photoelectric excitation of soft X-rays

given by the equation below:

(9)
Where KE is the kinetic energy of the released electrons as measured, hν is the energy of the
incident X-ray photons, BE is the binding energy of the electrons and

is the work function

of the spectrometer (detector).
As the KE, hν and

of the material and detector are known, the equation is used to

determine the binding energy of the electrons, allowing the instrument to probe the electronic
configuration of the sample (123,124).

Figure 3.6: A) general XPS schematic and B) example XPS spectrum. Source:
http://mcf.tamu.edu/instruments/xps
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The binding energies give rise to a unique set of peaks characteristic of the given
elements. Thus, by taking the ratio between the areas of the peaks, the elemental composition
of any sample can be determined.
A SPECS PHOIBOS 100 Analyser installed in a high-vacuum chamber was utilised
with the base pressure below 10–8 mbar. X-ray excitation was provided by Al Kα radiation
with photon energy hν = 1486.6 eV at the high voltage of 12 kV and power of 120 W. The
XPS binding energy spectra were recorded at the pass energy of 60 eV and 20 eV in the fixed
analyser transmission mode for survey scan and high resolution scan respectively. Analysis
of the XPS data was carried out using the commercial CasaXPS2.3.15 software package. The
elemental composition was calculated through area integration and comparison of the signal
peaks. This test was performed by Prof. Dongqi Shi from ISEM.

3.2.7

Energy Dispersive Spectroscopy

In order to confirm the surface oxygen concentrations of the two nanoceramics via a
separate technique, energy dispersive spectroscopy (EDS) was utilised. Performed in an
electron microscope, EDS makes use of the X-rays emitted from solid samples when
bombarded with an electron beam to perform a localised elemental analysis. The high energy
electrons are fired into the sample and displace electrons from all atomic orbitals

(125)

. The

outer shell electrons then drop down to fill the vacancies, producing characteristic X-ray
radiation which corresponds to the shell and element (126).
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Figure 3.7: Simple schematic of EDS mechanism.
Source: http://surfgroup.be/semedx

The analysis of the atomic composition from the detected signals is fairly straight
forward due to the relative simplicity of X-ray spectra, and is based on signal and peak
intensities. EDS does have difficulty detecting light elements where Z<10 and while the
technique is quick and accurate, the resolution is limited due to the penetration depth of the
electrons. The two materials were examined with EDS using the JSM-7500FA cold Field
Emission Gun Scanning Electron Microscope (FEGSEM) at the Electron Microscope Centre
in the Australian Institute of Intelligent Materials (AIIM). High energy electrons with an
accelerating voltage of 20.0 kV and a current of 10 μA were used to examine the
nanoceramic samples. The spot size of the beam was set to spot size 13 and the working
distance was 10 mm. There was between 2-3 kilo counts/second and a magnification between
200-500x. The composition of the nanoceramics was determined using the Bruker Esprit
software. The intensity of the characteristic secondary radiation for each element was
collected and measured. The ratio of Bi to O radiation intensities were then used to calculate
the atomic and weight percentages of each element in the sample. The characteristic radiation
associated with any trace contaminating elements (e.g. Carbon or Indium) were not taken into
account.
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3.3

Biological Characterisation

In this research, the difference in biological activity between the two compounds was
examined in two cell cultures. The first was the malignant 9L Gliosarcoma rat brain cancer
cells (National Cell Bank) and the second was the non-cancerous Madin- Darby Canine
Kidney (MDCK) cells (The European Collection of Cell Cultures) purchased through SigmaAldrich (LOT05/L/009). The protocols for the cellular characterisation experiments shown
are the same for both cell lines examined except for the seeding numbers as the two sets of
cells have different doubling times. All of these cell procedures were performed in a sterile
biological safety cabinet (BSC) to prevent contamination from airborne bacteria or fungi.

3.3.1

Cell splitting and counting procedure

The two cell lines were grown in T75 cm2 flasks from BD Falcon using prepared high
glucose Dulbecco's modified eagle medium (DMEM) media (section3.3.3). The flasks were
removed from the incubator set at 37 ˚C with 5% CO2, sprayed with ethanol then placed
inside the biological safety cabinet (BSC). The media was removed and the cells washed
twice with 5mL of Phosphate Buffer solution without calcium or magnesium (PBS (--)). 2
mL or 5 mL of Trypsin, for 9L and MDCK respectively, was then added to lift the cells from
the flask. The cells were then placed back in the incubator for a few minutes until they lifted
into suspension. The cell suspension was made up to 10 mL using the prepared media to
neutralise the Trypsin, and a small aliquot taken for cell counting in a 1 mL Eppendorf tube.
The tube containing the cells was vortexed to re-suspend the cells before sampling. A
10 l sample was taken and added to 50 l of Trypan blue solution (1:6 dilution) in a single
well of a 96 well plate. After mixing thoroughly with the pipette, 10 l of cell
suspension/Trypan blue was removed and the pipette tip placed close to the edge of the
haemocytometer cover slip. The stained suspension was gently dispensed into the space
between cover slip and the haemocytometer, the counting chamber, until the counting
chamber was filled, shown in figure 3.6 below:
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Figure 3.8: A typical haemocytometer.
Source: http://home.postech.ac.kr/~seotaiji/%B1%D7%B8%B2/cell_culture1.jpg

The haemocytometer was placed on the microscope stage. Using low power focus on
the ruled area, the grid was examined as shown below where each square millimetre is
divided into 16 squares (A-D) and the middle one (E) which divide into 25 squares.

E

Figure 3.9: Counting chamber of a haemocytometer.
Source: http://ink.primate.wisc.edu/~thomson/graphics/hemocytometer.gif and modified

The cells in each of the 5 grids were counted for both sides of the haemocytometer
and the average cells per grid of the 10 counts was used to calculate the concentration of cells
in the 0.1 l of suspension applied to the haemocytometer. The concentration of cells in the
original cell suspension was calculated using the following equation:

(Average number of cells per grid) x (dilution factor) x (10,000)

(10)

After the concentration was determined, the required volume for 1,500,000 9L cells / 100,000
MDCK cells was transferred into the T75 cm2 flasks and fill to 20 mL in volume.
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3.3.2

NP suspension preparation

3-5 mg of NP was transferred into a 15 mL Falcon tube and autoclaved with the lid
slightly unscrewed to prevent the tube from imploding. The lid was re-tightened as the tube
was removed from the autoclave to retain NP sterility, and 5 mL of PBS added inside a BSC.
The tube was then taped into a small container with the optimal water level and placed in an
ice bath. It was then sonicated with a Branson 250 Digital sonifier using a double stepped
micro tip. The sonicator was set to 70% amplitude with 100% duty cycle for 3 x 10 mins,
with the tube inverted multiple times between runs to ensure optimum dispersion. Finally, the
nanoparticle suspension was applied to the cells according to the required concentrations
using the equation:

C1V1=C2V2

(11)

Where C1 is the required concentration of the flask, V1 is the volume of the flask, C2 is the
NP suspension concentration and V2 is the volume of NP suspension required for C1.

3.3.3

Media preparation

The media utilised in this study was used for both 9L and MDCK cell lines. High
glucose Dulbecco's modified eagle medium (DMEM) from GIBCO was supplemented with
10% foetal bovine serum (FBS) (Bovogen) to provide sustenance for the cells, and 1%
Penicillin Streptomycin (Gibco) for protecting against contamination. This was then kept cold
and small 50mL aliquots drawn out for use to prevent any contamination to the main stock.

3.3.4

Plating Procedure

The 9L and MDCK cells were grown in T12.5 cm2 flasks and exposed to NPs using
the appropriate procedures (section 3.3.1-3.3.2). 9L cells were plated on Sigma 100 mm
diameter Petri dishes with an expected plating efficiency of 10%, while the MDCK cells were
plated on BD Falcon plates with an expected plating efficiency of 25% - 35%.
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Firstly, 100 mm Petri dishes were prepared and labelled in triplicate for a control and
nanoparticle at different concentrations. The cells were removed from the flasks using the
splitting procedure (section 3.3.2) and made up to a 2 mL stock. 0.2 mL of the 2 mL cell
stock was added to 2 mL of DMEM. This intermediate cell stock was then counted without
diluting with Trypan Blue and transferred using pipettes to seed the Petri Dishes with a total
DMEM volume of 10 mL. The initial seeding level was adjusted for the toxicity measured
during the exposure period, i.e. the death rate. For the control, it is accepted that the seeding
levels should be 1500 cells for 9L and 300 for MDCK. Using 9L cells for the example, the
required seeding levels (I) for cells exposed to the compound of interest, the given seeding
values were determined using the following relationship:

(12)

Where r is the cytotoxicity.
When seeding the plates, the cell suspension was taken “up and down” a dozen times
to ensure high cell transference and the media mixed from side to side to separate out the
individual cells, preventing colonies from combining. Once the plates had been seeded, they
were placed inside an incubator (37 ˚C and 5% (v/v) CO2) and left for 15 doubling times.

3.3.5

Fixing and Staining

After the required time had elapsed, the plates were removed from the incubators and
the media collected in waste. Every dish was washed with approximately 5 mL of PBS with
calcium and magnesium (+ +) twice, and discarded each time, to wash off any residual
media. Then approximately 5 mL of the staining solution, comprising of ¼ crystal violet & ¾
ethanol, was added to each dish. After five minutes the crystal violet/ethanol solution was
removed and the plates gently washed under a slow trickle of water. The plates were then
inverted and allowed to dry overnight. The number of colonies with cell populations over 50
was counted.
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3.3.6

Cell counting and Analysis

To investigate nanoparticle cytotoxicity, clonogenic survival was used as the
biological endpoint. The results of these experiments were analysed using the plating
efficiency and survival fraction. Each plate was counted and the number of colonies > 50
cells were recorded. These values were divided by the initial seeding number to give the
plating efficiency as shown:

(13)

The average PE of the control plates were then used to calculate the survival fractions (SF)
for the test plates. This was done by taking the ratio of the individual PE for each plate to the
average PE of the control (shown below). The normalised survival fraction allowed for the
cytotoxicity of the nanoparticles to be determined relative to the non-treated control, taking
into account the standard plating efficiency, with the control SF = 1.

(14)

3.3.7

24 Hour cytotoxicity

This procedure was used to determine the cytotoxicity of the two nanoceramics at a
standard concentration (50µg/mL) over 24 hours. This information was used later to adjust
the seeding numbers for the other biochemical tests, taking into account the toxicity. Cells
were seeded in 12.5 cm2 DB Falcon flasks, 300,000 for 9L and 40,000 for MDCK, and
allowed to grow until 80 – 90% confluence, between 1 and 1.2 million for 9L and 500,000 –
700,000 for MDCK. The two NPs suspensions were prepared as per the standard procedure
and were added 24 hours before plating, making a 50 μg/mL concentration of NP. The cells
were then trypsinated, suspended, and counted before being plated on the corresponding 100
mm Petri dishes and left for the respective incubation times. After the 15 doubling times had
elapsed the plates were fixed and stained and the colonies larger than 50 cells were counted.
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3.3.8

Concentration cytotoxicity

This procedure was used to determine the effects of NP concentration on the
cytotoxicity for the two nanoceramics. Cells were seeded in five 12.5 cm2 DB Falcon flasks,
300,000 for 9L and 40,000 for MDCK, and were allowed to grow until 80 – 90% confluence.
The two NP were prepared as per the standard procedure and were added 24 hours before
plating, making the concentrations of 0, 50, 100, 200 and 500 μg/mL. The cells were then
trypsinated and made into a cell solution before being counted and plated on the
corresponding 100 mm Petri dishes. After the 15 doubling times the colonies were counted
and results analysed.

3.3.9

Time assay

The time assay was used to investigate the cytotoxic behaviour of the nanoceramics at
different exposure times. T12.5 cm2 flasks were seeded for confluence in 4 days using the
standard splitting procedure (section 3.3.1) and a NP suspension made according to the
protocol (3.3.2). The NP suspension was applied to the cells at a concentration of 50 µg/mL
at 24, 48 and 72 hours before plating. The standard clonogenic assay procedure (section
3.3.4) was then followed and after 15 doubling times the plates were fixed, stained, and
counted (section 3.3.5 and 3.3.6).

3.3.10 Reactive Oxygen Species Detection Assay and Cell internalisation

The quantities of reactive oxygen species was investigated in connection to the
cytotoxicity and internalisation of the nanoceramics. 2’-7’-Dichlorofluorescein Diacetate (H2
– DCFDA) dye is photosensitive and as such, every tube was covered with aluminium foil.
The BSC, lab, and the flow cytometer room had the lights out and doors closed to minimise
light exposure. Twenty thousand cells were transferred to a 5 mL flow cytometer tube and
freshly prepared NP solution was added, filling to 0.5 mL total volume. Incubation times of 2
and 24 hours were used for both NP to initiate ROS generation/scavenging.
After the set time periods, the H2-DCFDA dye was added to make a final
concentration of 10 µM. The tubes were then placed back in the incubator for 30 mins to
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allow the dye to “load”, taken directly to the flow cytometer, and analysed with the green
laser. The settings for the flow cytometer are shown in appendix B. After 10,000 events were
detected, the results were gated to measure the viable cells only. The average fluorescence for
the cells was recorded.
Cell internalisation was performed as part of the ROS detection assay. The degree of
internalization of the nanomaterials was determined with the FACSDiva software, assessing
both forward and side scatter intensities. The intensity of the forward-scattered light (FSC) is
proportional to the size and surface area of the cell and does not change with the degree of
internalization. However, the side-scattered light (SSC) is proportional to the cell granularity
and is used to examine the cellular uptake of nanoparticles (127).

3.3.11 Clonogenic radiation survival curves

The radiation experimentation was performed using the facilities at Prince of Wales
Hospital, under the supervision of Dr Stéphanie Corde, in order to evaluate the radiation
enhancement capability of the nanoceramics. The two energies examined were 125 kVp,
which is the calculated optimum of the absorption coefficient normalised by the water (see
Appendix A), and 10 MV, which is commonly used in radiation therapy. Cells were seeded at
three doubling times before confluence so they could fully adhere to the flask. The bismuth
oxide NPs were added to the flasks 24 hours before irradiation. For kilovolt irradiation, the
T12.5 cm2 flasks made up to 6 mL total volume of DMEM with a depth of 6 mm when laid
flat. For irradiation with the 10 MV linear accelerator, the flasks were filled with Hank’s
balanced salt solution (HBSS) to ensure the electronic equilibrium conditions were present at
the level of the cells. The flasks were arranged with treated and untreated samples irradiated
together. After the irradiation the samples were taken back to IHMRI and plated using the
procedures previously outlined in section 3.3.4. The results were analysed using the counting
procedure (section 3.3.6) with each curve, treated and untreated, normalised against their
respective 0 Gy flasks. The resulting survival fractions were then fitted with a linear
quadratic exponential curve (shown below) to determine the sensitisation enhancement ratio
(SER). The SER is the ratio at the intercept of the 0.1 survival fraction line of the untreated
curves to the nanoparticle treated curve.
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This is a standard measurement in the field of radiosensitisers to describe the effectiveness of
a sensitiser.

(15)
Where: SF is the surviving fraction, D is the radiation Dose (Gy), α and β are the cell
radiosensitivity coefficients (Gy-1 and Gy-2).

3.3.12 Statistical Analysis

In order to determine if the results obtained from the clonogenic based experiments
were significant, statistical analyses were employed. The results from the biological
experiments were replicated and measured in triplicate on each occasion. Statistical analysis
of toxicity and ROS data was performed using a two-tailed Student's t-test with the
assumption of equal variance. A P value ≤0.05 was considered statistically significant. This
statistical analysis was used as it is the standard method for analysing the significance of
results in biological research and publications

(52)

. The P values are a measure of the

likelihood that experimental results will fall outside the standard deviation (shown by the
shaded areas below).

Figure 3.10: P value explanation.
Source: http://www.scielo.br/scielo.php?pid=S0034-72802014000100016&script=sci_arttext&tlng=en
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The P values were calculated using the “TTEST” function in EXCEL. After selecting
the two sets of data, the calculations were made for 2 tails and assuming equal variance.
[=TTEST(X, Y, 2, 2)]
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4. Results

4.1

Materials Characterisation

4.1.1

Thermogravimetric Analysis/Differential Scanning Calorimetry

Figure 4.1: DSC/TGA of Bi2O3 precursor under different atmospheres

The DSC/TGA results were used as a starting point for the annealing of Bi2O3. In the
range from 50 ˚C to 180 ˚C, the Bi(OH)3 precursor was converted into Bi2O3 during the initial
loss of water, as shown by the large spanning peaks. After this the ceramic is in the alpha
phase until the temperature reaches 480 ˚C where there is an alpha – gamma (α-γ) phase
transition followed quickly by a gamma – beta (γ-β) transition at 530 ˚C. The two phase
transitions are close together as the temperature range for Bi2O3 gamma phase lies within the
temperature range for beta phase

(128)

. The materials remain beta phase until they reach

˚

approximately 730 C where they undergo the beta- delta (β – δ) phase transition. Past 830 ˚C
the ceramics melt and the atmospheres have different effects on the slurry. The air
atmosphere produces a final product which was a cooled single mass of bismuth oxide
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ceramic, however, when the ceramic was liquefied under argon atmosphere the final product
was pure bismuth metal. This is explained by the additional phase transition at 830 ˚C under
the argon atmosphere, where any remaining oxygen is released from the liquid slurry due to
the extreme heat and minuscule oxygen partial pressure resulting in the reduction from Bi(III)
to Bi(0).
The TGA results showed different weight loss behaviours associated with the loss of
oxygen from the ceramic, depending on the atmosphere. There was a large initial weight loss
in the argon atmosphere, explaining the loss in water, after which the weight dropped slowly.
During the molecular rearrangements of the close gamma and beta phase transitions the
weight dropped again, then remained relatively constant, detecting a small weight loss for the
remaining temperatures. The air atmosphere has a different behaviour, losing weight
gradually up to 250 ˚C because of the presence of oxygen. At approximately 450 ˚C the
weight dropped dramatically during the transition from alpha to gamma to beta phases and
plateaus after the formation of beta phase, like the argon atmosphere. It was from these
results that the annealing temperatures of 530 ˚C and 550 ˚C were chosen for the argon and air
annealed nanoceramics. A few attempts were made to reduce the annealing temperature
further to minimise the crystal growth and make smaller nanoparticles but this caused the
formation of mixed phases of α and γ Bi2O3.
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4.1.2

X-Ray Diffraction

Figure 4.2: XRD spectra of Air and Argon annealed Bi2O3 NPs. Inset: a typical NP agglomerate TEM.

The two nanoceramics were synthesised forming yellow powders. The air annealed
samples portrayed a strong yellow colour and the argon annealed samples had a pale yellow
colour. The XRD spectrum of the two bismuth oxide NPs were analysed using the X-Ray
diffraction program “Traces”. It showed both materials were in the Bi2O3 α-phase

(129)

characterised by the Traces phase card 06-0294. The crystal size of the two materials was
also calculated from the XRD spectrum, having three size ranges fitting the known
morphology of the nanoplatelets

(130)

. The platelets have submicron X and Y dimensions,

length and breadth, however, the Z dimension, thickness, has a range from 50 – 80 nm. These
sizes were calculated using the peaks and Miller indices shown on the figure and later
confirmed by TEM, which showed flat platelets with submicron parameters, yet were very
transparent which indicated a nanoscale thickness. The lattice parameters of the α-Bi2O3 are
5.83Å, 8.14Å and 7.48Å for a, b and c with an internal angle of β= 67.07˚ as stated on the
data card.
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4.1.3

Transmission Electron Microscopy

Figure 4.3: HR-TEM image of Bi2O3 nanoceramic platelets.

The images from the TEM confirmed the material platelet morphology and the
physical parameters observed in the XRD. The X and Y dimensions of the nanoceramics
were in the submicron dimensions with some aggregates being over 1.5 microns, but the Z
parameter was shown to be in the nanoscale, denoted by the translucency of the platelets.
Like most nanomaterials, the nanoplatelets are highly agglomerated in the dry powder state
with the heavy elemental composition and stacking nature of the platelets causing difficulty
for some characterisation techniques, such as BET surface area. The electron density of the
bismuth atoms impeded the transmission of the electrons used for imaging which caused the
platelets to appear thicker than they are. The agglomerates were able to be dispersed through
proper sonication procedures (section 3.2.2) which resolved this issue in the biological
testing.
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4.1.4

UV-vis Spectroscopy

Figure 4.4: Absorption Spectra of Bi2O3 nanoceramics.

The maximum absorbencies for the nanoceramics were 0.675 for argon and 0.735 for
air at the optimal concentration of 0.5 g/L. This occurred in the UVC/UVB region of the
spectrum between 270 - 300 nm. The band gap energy (Eg) was calculated using the given
equations (section 3.2.4). Both Eg were within the accepted range of values for alpha phase
Bi2O3

(131)

, however, the argon annealed nanoceramic had an Eg of 2.3 ± 0.1 eV which was

consistently lower than the air annealed 2.7± 0.1 eV. Bi2O3 is a known semiconductor and
coupling the difference in colour with the lowering of the Eg indicates that the conductivity of
the material has increased due to the presence of more surface Bi metal atoms.

48

4.1.5

Methylene Blue Surface Area

Figure 4.5: Langmuir plot of Bi2O3 nanoceramics for determination of surface area .The red square is the
optimum weight adsorbed MB: Bi2O3 to weight added MB: Bi2O3 (cation replacement concentration)

The absorption of each Methylene Blue (MB) sample was measured against the
calibration curve to determine the actual solution concentration for comparison against the
known concentration. These values were converted from g/L to weight ratios of the adsorbed
MB: Bi2O3 and the added MB: Bi2O3. The values were then plotted against each other to
make a Langmuir curve and the ion replacement concentration was used to determine the
surface area (shown in red above). Using equation 4 (section 3.2.5), the surface area of the
NPs was determined to be 48.7 ± 4.5 cm2/g. Unfortunately there were no surface area values
for the nanoceramic platelets in literature for a comparison. However, this surface area is an
appropriate value for nanoparticles as a rule. Correct sonication procedures played an
important part in this test due to the highly aggregated nature of the nanoceramic platelets.
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4.1.6

X-ray Photoelectron Spectroscopy

A)

B)

Figure 4.6: XPS spectrum for Bi2O3 in regions for A) 1s oxygen and b) 4f and 5d bismuth.

The peaks shown are characteristic peaks of Bi2O3 with each peak corresponding to
the binding energy of electrons in particular orbitals. The two materials were probed for the
presence of a reversible redox system like cerium dioxide, and to investigate the oxygen
concentrations at the surface of the two nanoceramics. The 1s peak of oxygen is found at 535
eV and the 4f Bi peaks were located at 163 and 168 eV. The lower of these two peaks was
characterised as the 4f7/2 Bi peak corresponding to the Bi(0) oxidation state, while the higher
is the 4f5/2 peak and corresponded to the Bi(III) oxidation state

(132, 133)

. By integrating these

peaks and comparing the area, the atomic and weight concentrations of bismuth and oxygen
in the Bi2O3 nanoceramics were calculated. The Bi 5d peak was used to determine the oxygen
concentrations of the NPs instead of the 4f peaks as the 5d peak has clearly defined
boundaries, while the 4f peaks are located next to a signal drop and a clear boundary is not
apparent.
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The atomic concentrations and weight concentrations were calculated for each nanoceramic
and are shown below:

Table 4.1: Atomic composition of nanoceramics from X-ray photoelectron spectroscopy.

Sample

Atomic% (oxygen)

Weight%

Argon annealed

46.82 ± 1.92

6.31 ± 0.25

Air Annealed

51.63 ± 1.49

7.56 ± 0.22

The results show that the argon annealed nanoceramic has a 1.25 weight% reduction
in surface oxygen compared to the air annealed, signifying that the differences between the
two materials is based on the surface oxygen content.

4.1.7

Energy Dispersion Spectroscopy

The atomic composition of the nanoceramics was determined using the sample
principle as the XPS. The atomic% and the weight% for oxygen and bismuth were calculated
by integrating the area under the curves and taking the ratio of the areas. Multiple regions of
the nanoceramic samples were probed using this technique to gather a representative value of
each sample for comparison (figure 4.1.7). The results from the EDS confirmed the results
obtained from the XPS, showing a definite oxygen loss of 1.24 weight% in the argon
annealed nanoceramic compared to the air annealed.
Table 4.2: Atomic concentration of bismuth oxide nanoceramics as determined by EDS.

Sample

Atomic% (oxygen)

Weight%

Argon annealed

50.95 ± 1.73

7.38 ± 0.47

Air Annealed

55.16 ± 1.35

8.62 ± 0.43
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Figure 4.7: A) EDS surface and B) secondary radiation spectrum.
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4.2

Biochemical Characterisation

4.2.1

24 Hr Cytotoxic Clonogenic assay

Figure 4.8: 24 hours Cytotoxicity assay for 9L and MDCK cells at 50 µg/mL. 9L cytotoxicity P value ≤ 0.005
and MDCK cytotoxicity P ≤ 0.0001.

The 24 hr cytotoxic clonogenic assays were the first tests to be run, with the purpose
of determining the cytotoxicity of the two nanoparticles. The results showed different
activities based on the cell - material combination and the concentration of 50 µg/mL used for
a comparison with gold and tantalum oxide NPs. The 9L - argon combination demonstrated
biocompatibility with a survival fraction was 0.98±0.09, while the 9L - air combination only
had an SF = 0.70±0.05. In the non-malignant MDCK cell line, the air annealed nanoceramic
had a reduction in cytotoxicity compared to the 9L with a survival fraction of 0.79±0.08,
while the argon annealed nanoceramic had a cell proliferation effect with a survival fraction
of 1.22±0.15. These results showed that there was a difference in cellular activity dependent
on the annealing atmosphere of the two nanoceramics and the surface oxygen deficiencies.
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4.2.2

Concentrations assay

The two nanomaterials had unique concentration behaviours for each cell-NP
combination. At 500 µg/mL the cytotoxic nature changes as the biological processes of the
cells takeover from the chemical and physical effects of the nanomaterials.
In the 9L cell - air annealed combination; the 50 µg/mL concentration has an SF of
0.71±0.03 then drops sharply to 0.30 ±0.06 for the 100 µg/mL concentration. The SF
continued to drop with the 200 µg/mL concentration, SF=0.23±0.04, and the material was
found to be completely toxic at 500 µg/mL with a survival fraction of essentially 0. This
result is understandable as the air annealed nanoceramic was shown to be an ROS generator
of particular effectiveness (section 4.2.5), and coupling the concentration based toxicity with
the high levels of ROS generation, an SF of 0 at a concentration 10 times that of normal
treatments is expected.
The 9L - argon cell combination did not demonstrate as radical concentration toxicity
effects. Starting with SF of 0.94±0.09 for 50 µg/mL, the survival fraction decreased to 0.61
±0.11 for the 100 µg/mL concentration. The cytotoxicity then plateaus at the 200 µg/mL and
500µg/mL concentrations with survival fractions of 0.51±0.12 and 0.56±0.13 respectively.
This confirmed that the argon annealed materials is more biocompatible than the air annealed
over a range of concentrations.
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Figure 4.9: The effects of nanoparticle concentration on 9L cells clonogenic survival. 50 µg/mL P ≤ 0.01, 100
µg/mL P ≤ 0.0005, 200 µg/mL P ≤ 0.01, 500 µg/mL P ≤0.01.

The MDCK - air combination had the same gradual increase in toxicity demonstrated
by the argon annealed nanoceramic in the 9L cells. The survival fractions for the
concentrations are 0.80±0.07 for the 50 µg/mL, 0.66±0.06 for the 100 µg/mL, 0.61±0.04 and
0.62±0.08 for the 200 and 500 µg/mL concentrations respectively. These results are
characteristic of the gradual decrease in SF associated with an increasing quantity of foreign
materials.
The MDCK - argon combination demonstrated an SF decrease with the concentration
but this was counteracted by the growth enhancement capacity of the nanoceramics, resulting
in survival fractions equal to or greater than the control. The cell proliferation activity of the
argon nanoceramic dominated in the 50 µg/mL and 100 µg/mL concentration with survival
fractions of 1.17±0.15 and 1.14±0.09 respectively. The cytotoxicity effect of the increased
material concentration started to take over at the higher concentrations of 200 µg/mL and 500
µg/mL. The survival fraction drops slightly below the control with values of 0.90±0.13 and
0.88±0.21 respectively. Statistical analysis was performed on the argon annealed
concentration results because of the overlapping uncertainty bars and showed that all
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concentrations had p > 0.1, indicating no statistically significant difference between the argon
concentrations and the control. From this, the argon annealed nanomaterial was shown to be
biocompatible at all concentrations in the MDCK cells.

Figure 4.10: Concentration based cytotoxicity of argon and air annealed Bi 2O3 nanoceramics on MDCK cells.
50µg/mL P ≤ 0.005, 100µg/mL P ≤ 5x10 -6, 200µg/mL P ≤ 0.001, 500µg/mL P ≤ 0.01.

4.2.3

Time exposure assay

In the clinical situation, nanomaterials used for treatments will not be in the body for
just 24 hours, with most taking a number of days to be removed from the body via natural
means. This assay was performed to measure the cytotoxicity of a 50 µg/mL NP
concentration as a function of time in both 9L and MDCK cells over three days of exposure.
On the 9L cells, at 24 hours the survival fractions fell within the previously stated results of
the cytotoxic and concentrations assays (section 4.2.1 and 4.2.2). At 48 hours the argon
annealed SF dropped to 0.75 ± 0.13 and the air decreased slightly to 0.68 ± 0.16. Finally at 72
hours the cytotoxicities were 0.76 ± 0.07 and 0.65 ± 0.01 for argon and air respectively. Both
results showed a trend of increasing toxicity as the exposure time increased, with the
biocompatible argon annealed nanoceramic demonstrating a more radical change than the air
annealed, while still retaining a higher SF.
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Figure 4.11:24, 48 and 72 hour exposure time assay of nanoceramics on 9L cells at 50 µg/mL.

The exposure based toxicity trend was also present in the MDCK with similar results
to that of the 9L for the argon and air annealed nanoceramics. As in the case of 9L, the 24
hour exposure results correlated with the established toxicity and proliferation results, with
the argon cytotoxicities dropping drastically from 1.22 at 24 hours to 0.92 ± 0.10 at 48 hours
and 0.69 ± 0.08 at 72 hours exposure. The air annealed nanoceramic did exhibit some
interesting behaviour in the extended time frames with an increase in SF from 0.79 ± 0.08 at
24 hours to 0.94 ± 0.06 at 48 hours. This temporary increase in survival fraction was not
maintained by the air annealed nanoceramic because at 72 hours the SF dropped to 0.68 ±
0.02.

57

Figure 4.12: 24, 48 and 72 hour exposure time assay of nanoceramics on MDCK cells.

4.2.4

Cell internalisation

This test was used to determine how much nanoceramic is taken into the cells and was
performed as part of the reactive oxygen species assay (section 3.3.9). As nanomaterials are
internalised they change the granularity of the cells, which is shown by a shift in the position
of the side scatter compared to the controls. The results showed that the air annealed
nanoceramic was internalised more than the argon at 2 hours, but after 24 hours it was the
argon annealed with a higher SSC than the air annealed in the cancerous 9L cell line. The
SSC values for 24 hours were approximately double the values received for the 2 hour. The
internalisation ratios for the 9L sets are 5.23 and 6.98 at 2 hours and 7.23 and 6.48 at 24
hours for the argon and air respectively. A similar internalisation trend was observed in the
MDCK cells, however, at both 2 and 24 hours the argon annealed nanoceramic had higher
internalisation than the air annealed. As in the case for 9L cells, the internalisation at 2 hours
was a little under half of the internalisation at 24 hours, indicating that the internalisation
process requires longer periods of time to complete. The internalisation ratios for the MDCK
are 5.57 and 5.03 at 2 hours and 3.59 and 3.20 at 24 hours for the argon and air respectively.
The 24 hour ratios are approximately half of the 9L equivalent because of the high SSC of the
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controls. This was repeated three times but remained considerably high at twice the values for
the 2 hours.

Table 2.3: mean SSC values for 9L and MDCK cells at 2 and 24 hours. Full data in Appendix B.

Time (hours)

Control

Argon annealed

Air annealed

2

206 ± 29

1080 ± 2

1441

24

357 ± 6

2584 ± 124

2303 ± 127

2

160 ± 32

888

802

24

617 ± 80

2215 ± 124

1972 ± 107

9L

MDCK

4.2.5

Reactive Oxygen Species Assay

The quantity of ROS within the 9L and MDCK cells was investigated using H2DFCDA dye. The dye is oxidised in the presence of ROS, detected by a lowering in the
absorption/emission spectrum. This provided a relative measurement of ROS levels within
biological systems under oxidative stress (OS). These levels were measured at 2 hours and
24 hours to investigate the connection between ROS generation and the observed
cytotoxicity. As shown in section 4.2.4, at 2 hours both nanoceramics have only been
partially internalised compared to the 24 hours and the OS can differ greatly. For the argon MDCK and the argon - 9L combinations, there were reductions in ROS levels between the
two times while the reverse occurred in the air annealed nanoceramic combinations. The
initial OS was low, between 0.6-0.8, but as the amount of nanoceramic internalised increased
the ROS levels increased dramatically, almost doubling for the air - 9L combination. From
these results we can see that the annealing atmosphere had a significant effect on the
biological activity of the nanoceramics. By creating the oxygen deficiencies in the argon
annealed material, the nanoceramic had changed ROS activity from an ROS generator, like
the air annealed, to an ROS scavenger. This scavenging effect was limited by the number of
oxygen deficiencies exposed to the cellular environment.
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Figure 4.13: ROS levels for Bi2O3 nanoceramics at 2Hr and 24Hr time intervals. 2 hr: 9L ROS P value ≤0.05
and MDCK≤0.05. 24hr: 9L ROS P value ≤ 0.01 and MDCK ROS P value ≤ 0.05.

4.2.6

Radiation experiments

As mentioned previously, the procedure for radiation experiments was labour
intensive and time consuming, as 15 doubling times are required between the low density
subculture and the staining process for the clonogenic procedure. The survival fractions for
each dose were calculated using the standard counting procedure with a minimum of three
samples (section 3.3.6). Each survival curve was repeated 3 times. The resulting experimental
points were fitted using the linear quadratic exponential equation (section 3.3.11). The α and
β coefficients were extracted from these curves and used to determine the SER0.1 for both the
argon and air annealed Bi2O3 samples. Radiation was performed on 9L cells only as the focus
for this project was to develop a new radiosensitiser.
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4.2.6.1

125 kilovolt survival curves

Figure 4.14: Survival curves of 9L cells treated with argon and air annealed Bi2O3 nanoceramics under 125
kVp x-ray radiation. SER = 1.31 for both nanoceramics.

The first radiation energy examined was 125 kVp, which corresponded to the
calculated optimum energy of Bi2O3 (see appendix A), and is used for treatment of superficial
cancers. Both the air and argon annealed nanoceramics were examined to determine if the
difference in oxygen concentration affected the performance. After extracting the α and β
parameters from the linear quadratic curves, the SER was calculated for each nanoceramic.
Both the argon and air nanoceramic curves were shown to have the same SER of 1.31,
demonstrating both materials are highly effective radiosensitisers. However, judging from the
shape of the curves it is clear that the argon annealed nanoceramic was the more effective due
to the linear nature and the lower SF values for each dose point. For these reasons the argon
was chosen to be examined under 10 MV radiation.
Table 4.4: α and β co-efficients and SER for control & Bi2O3 curves from quadratic exponential equation.

Curve

α – coefficient (Gy-1)

β – coefficient (Gy -2)

SER

Control

0.075 ± 0.040

0.017 ± 0.006

1

Bi2O3 – Argon

0.405 ± 0.032

0.013 ± 0.005

1.31

Bi2O3 – Air

0.100 ± 0.067

0.029 ± 0.011

1.31
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4.2.6.2

10 Megavolt survival curves

Figure 4.15: 10MV survival curves for 9L cells with argon annealed Bi2O3.

The argon nanoceramic was examined under 10 MV radiation to investigate how
effective it would be for treating deeper seeded cancers, like bowel cancer, compared to gold.
The analysis of the curves produced an SER of 1.25 for the Bi2O3 nanoceramic, which is
equivalent to gold nanoparticles. This result is expected as the enhancement on megavolt
treatments is proportional to the Z of the elements used and Bi2O3 has an effective Z of 79.6,
almost the same as Gold (Z=79). The gold nanoparticles in these studies were much smaller
and were performed on less radioresistant cell lines, therefore, the Bi2O3 was more effective
despite the same SER. While this material was equal with Au NPs this shows that that further
materials development is required to optimise the enhancement under 10 MV through the
production of smaller nanoplatelets, if it is to supplant gold in MV treatments.
Table 4.5: α and β co-efficients and SER for control & Bi2O3 curves from quadratic exponential equation.

Curve

α – coefficient (Gy-1)

β – coefficient (Gy -2)

SER0.1

Control

0.14978 ± 0.02982

0.01259 ± 0.00526

1

Bi2O3 – Argon

0.25646 ± 0.0543

0.00904 ± 0.00695

1.25
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5. Discussion

5.1

Material tailoring

5.1.1

Synthesis and Annealing

The precipitation synthesis method was selected for this study as it provided the most
versatile method to tailor the oxygen content. There are other syntheses which stated the
production of smaller nanoplatelets, but they did not allow oxygen tailoring through
annealing atmosphere as they required oxygen to burn off additional carbon based sol-gel
components

(128, 133 - 135)

. The selected precipitation method was simpler to perform and

produced materials shown to be extremely consistent between batches as demonstrated by
SEM, TEM and XRD. This procedure was also clean of any contamination by other elements
as the ammonia nitrate formed during the synthesis is water soluble and easily removed
through washing. Coupled with a final annealing temperature of over 500 ˚C any remaining
interstitial ammonia nitrate compounds in the material lattice were removed, producing a
pure Bi2O3 product. The annealing temperatures used for the synthesis of the bismuth oxide
were derived from the DSC/TGA, but needed to be increased slightly for use in the tube
furnace. The tube furnace used was suitable for the final annealing, but use of the two
atmospheres changed the air flow dynamics within the furnace. When annealing under argon,
rubber stoppers were inserted in the openings of the furnace with two tubes inserted through
the rubber stoppers allowing for the ingress and egress of argon gas forming a stable gas flow
dynamic. The absence of an air flow line meant the air annealed materials could not be done
in this manner, thus, the ends of the tube were left open allowing air to flow freely through
the furnace. This required a slightly higher annealing temperature and resulted in the slight
increase in crystal size for the air annealed nanoceramic.

5.1.2

Nanoceramic aggregation and characterisation

One of the main problems with all nanomaterials is aggregation (136, 137) and Bi2O3 was
no exception due to the combination of heavy elemental composition and nanoplatelet
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morphology. This issue of aggregation provided complications for a few important
characterisation techniques: UV-vis, gas desorption surface area (BET), and electron
microscopy. This also causes problems for biological experiments as a small particle size is
essential for cell internalisation and radiation enhancement. This was corrected for the UVvis and electron microscopy by sonication in an ultrasonic bath for >2 hours, and for the
biological assays the nanoceramics were formed into a suspension using a high powered
sonicator. These still showed a high level of settling with the nanoceramic falling out of
suspension rather quickly.
The size of the nanoceramic crystals and aggregates were examined with every batch
synthesised using XRD, SEM and TEM. They all showed that the nanoceramics had
consistent sizes between batches with nano-thin platelet morphologies. While XRD had no
damaging effects on the nanoceramics, SEM and TEM were different. Between the high
acceleration voltages of the electrons used for electron microscopes, the intensities associated
in the focal regions (spot sizes), and the semiconductor behaviour of the bismuth oxide
nanoceramics, the surface of the materials became charged and formed an amorphous Bi2O3
layer resulting in difficulty during the imaging process. This was taken into account by
lowering the accelerating voltage when possible, and while being effective in the SEM it was
still an issue under TEM examination.
The absorption spectra of the two materials both show peaks in the UVC/UVB region
of the spectrum. The air annealed nanoceramic has a slightly higher absorption than the argon
as expected from the transition selection rules, as the air annealed material is a strong yellow
colour while the argon annealed is a pale yellow.
BET gas desorption was originally used for determining the surface area of the Bi2O3
NPs, but it was found that the oxygen was stripped from both materials under the lower
pressures and N2 atmosphere used for drying the powders. The materials changed colour from
yellow to a chocolate brown, indicating a material change, and the calculated result would not
necessarily represent the surface area of the materials in the synthesised oxide state. The
reading obtained from the BET stated a surface area of only 0.5 cm2/gram, which was
definitely a result of aggregation. As such, the older solution based method of Methylene
Blue surface area (MBSA) detection was used. This was more suitable for these materials for
the following reasons:
Firstly, the nanoceramics can be correctly suspended in solution providing a more
accurate particle size. The morphology of the Bi2O3 nanoceramic is nanoplatelets which pack
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flat and lose the majority of the surface area when aggregated. When measured by the BET,
the nitrogen is only adsorbing to the platelet edges and gives false readings. This is not an
issue for the solution based method as the aggregates are broken apart forming more accurate
particle size, shown by approximate 100x increase in surface area from 0.5 cm2/g to 48.7
cm2/g.
Secondly, this material is being applied in a liquid based biological environment. In
suspensions all nanoparticles form aggregates of particular sizes based on the zeta potential
(136)

. This can greatly alter the interactions with cells for internalisation as the interactions are

not only based on size but also on surface charge. Therefore, the surface area of the dry
powder will not necessarily reflect the surface area of interaction in the suspension. As such,
using a suspension/liquid based surface area method gives a more applicable value for
understanding the NP-cell interactions. Despite the materials based work done on Bi2O3 there
was no reference for the surface area of the nanoceramic platelet morphology for comparison
with our product.

5.1.3

Oxygen Concentration

Since the DSC/TGA test did not show any difference in weight provided exclusively by
the oxygen concentration due to the sensitivity of the instrument, the two Bi 2O3 nanoceramics
were examined using both XPS and EDS to determine oxygen concentrations. These
techniques use high energy beams of X-rays or electrons to excite the surface molecules of
the nanoceramics causing them to release characteristic secondary radiation. The
characteristic radiation signals are then used to determine the atomic composition of the
samples. Both of these techniques revealed that the argon annealed nanoceramic had lower
oxygen content than the air by 1.24 ± 0.01 weight%. There is a difference in composition %
between the two techniques due to the techniques themselves, as the EDS technique has a
deeper penetration than XPS. In EDS, the sample is bombarded with high energy electrons
which penetrate deeper into the sample. These electrons interact with the oxygen deeper in
the material lattice and produce more oxygen signals. XPS uses X-rays and only penetrates at
a superficial layer of the material, thus, giving a lower overall oxygen content. Despite this
difference, both techniques demonstrated a definite reduction in surface oxygen in the argon
annealed nanoceramic compared to the air.
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5.2

Biochemical behaviour

In cell work the time taken to acquire results, either positive or negative, is dictated by the
growth of the cells. All clonogenic assays take a number of weeks to grow to find out
whether the test was successful or not. Cell experiments take a week to set up then between
11 and 21 days to grow depending on the cell line. After fixing and staining, the plates need
to be counted and analysed. This is a very time consuming process for confirming results and
multiple repetitions are often required.

5.2.1

General Cytotoxicity and ROS

The nanoceramics show different chemical activity for the two cell lines as
demonstrated by the 24 hour cytotoxicity assay. The difference in the two nanoceramics is
due to the presence of the oxygen deficiencies on the surface of the argon annealed material.
These oxygen deficiencies take the form of positive holes in the material lattice granting the
nanoceramic a scavenging capability with the free ROS inside cells. This scavenging capacity
is limited by the amount of oxygen deficiencies present on the surface of the material
exposed to the cellular environment. The scavenging mechanism is similar to that of cerium
dioxide

(138)

, but without the reversibility. The oxygen deficiencies act as scavenging sites

reacting with the ROS to complete the lattice structure, filling the electron vacancies. Unlike
the cerium dioxide, the chemical reaction is not reversible as the XPS confirmed the absence
of a reversible redox system as present in cerium dioxide

(139)

. These positive holes in the

lattice, or lack thereof in the case of the air annealed, work in tandem with the pH of the cells
to produce the cellular survival fractions observed. The 9L gliosarcoma cells are hypoxic
with a lower pH than the neutral MDCK cells. This pH affects the chemical activity of the
nanoceramics enhancing the cytotoxicity of the air annealed nanoceramic while reducing the
proliferation of the argon annealed. This explains why the argon annealed nanoceramic is
only biocompatible in the 9L, showing no increased cell death, while causing growth
enhancement in the MDCK. This pH difference also alters the activity of the air annealed
nanoceramic, triggering the release of more ROS and increases the cytotoxicity by 10% in the
9L.
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5.2.2

Nanoceramic Concentration

The concentration based cytotoxicity of the two nanoceramics is a balance between
the accepted NP concentration to cytotoxicity relationship, and the ROS effects shown by the
concentrations assay. As the concentration of nanoparticle increases in a biological system,
the cytotoxicity naturally increases due to the presence of a foreign body. This trend is
present in all nanoparticles, biocompatible or not

(14,54)

. The two ROS neutral combinations,

argon-9L and air-MDCK, exemplified the accepted trend with increasing toxicity as the
material concentration increases, resulting in cytotoxicities between 40-50%. The two ROS
active combinations, argon-MDCK and air-9L, showed activities that were a combination of
their chemical activity and material concentration, balancing the toxicity associated with
increasing foreign material and the increasing amount of chemical effects, either helpful or
harmful. The argon-MDCK combination showed a counter balance of the cell proliferation
and toxicity keeping the SF >0.8, even at the high concentrations, while the air-9L cell
combination demonstrated an enhanced killing effect from the ROS generation resulting in
100% cytotoxicity at 500 µg/mL.

5.2.3

Exposure time

The cytotoxicity of the nanoceramics is dependent on the exposure time, as shown by
the ROS assays and the exposure time assays. The exposure time assays measure the
chemical activity of the nanoceramic over a series of days to determine any ongoing
cytotoxicity not noticeable over the 24 hour exposure. A comparison of the air and argon
annealed nanoceramic results show an overlap in the SF values for MDCK and the 48 hour
9L, with the 72 hour 9L results having close values (Figure 4.2.11- Figure 4.2.12). These
results could be explained if the NPs reach an activity saturation. This would explain the
gradual decrease in SF observed in both cell lines, and why the air annealed nanoceramics
show less overall change than the argon annealed.
In the MDCK cells, the results for the argon annealed are consistent with the
nanoceramic losing its ROS scavenging property and becoming more cytotoxic as the time
increases. This may be due to the slow recombination of the cellular ROS with the oxygen
vacancies in the material lattice. The scavenging activity ceases between 24 and 48 hours
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followed by increasing levels of ROS, which result in the observed cell death at 48 and 72
hours. A similar trend appears in the 9L cells but is less severe due to the hypoxic cellular
environment. The argon annealed nanoceramic demonstrates biocompatibility until the
activity saturation between 24 and 48 hours. After this, the ROS levels increase and remain
constant in the 48 and 72 hour results.
While the air annealed nanoceramic does not have oxygen vacancies in the material
lattice, it seems to demonstrate two different trends depending on the cell line. In 9L cells the
air annealed generates large amounts of ROS at 24 hours (Figure 4.2.13). As a result the cells
cannot recover after the activity saturation and the toxicity remains consistent over the three
days. In the MDCK cell line the air annealed generates much less ROS than in the 9L as
shown by the ROS assay (Figure 4.2.13). During the activity saturation between 24 and 48
hours, the ROS must reduce enough for the MDCK cells to recover. Then between 48 and 72
hours, the ROS generation activity is re-established, increasing the ROS in the cells
provoking the decrease of the SF again.

5.3

Radiation enhancement

As mentioned previously (section 5.2) the process for clonogenic assays is very time
consuming. For radiation survival curves the process is even more time consuming, as the
samples need to be transported to the radiation oncology department at Prince of Wales
Hospital, Randwick, to be irradiated under the supervision of Dr Stéphanie Corde. After
returning to IHMRI, the cells need to be plated in one sitting which takes upwards of 7 hours.
All results are repeated multiple times depending on their agreement with each other.

5.3.1

125 kVp Survival Curves

The energy of the kilovolt radiation was determined through the calculation of the optimum
absorption energy for Bi2O3 (appendix A). While kilovolt radiation treatments are not used in
many cancer cases due to its low penetration, there are still types of cancers which undergo
the superficial kV irradiation treatments, e.g. inoperable skin cancers and prostate cancer

(141,

142)

. The curves of the Bi2O3 nanoceramics demonstrated two different natures with the

oxygen deficient argon annealed nanoceramic being highly linear and, therefore, more
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effective than the unmodified air annealed. These natures are indicative of a change in
electron spectrum between metals and metal oxides, indicating that the argon annealed
nanoceramic has a more metallic surface. This is in keeping with the known oxygen
deficiencies on the surface of the argon nanoceramic.
The SER values for the two nanoceramics were the same (SER= 1.31) at the 0.1 SF
line and are comparatively better than gold NPs and tantalum pentoxide NSPs (section2.3.3
& 2.3.5). Ta2O5 (Zeff = 69) and gold NPs (Z = 79) have Z’s less or equal to bismuth oxide (Zeff
= 79.68), but still do not match the enhancement of the Bi2O3. Therefore, the effectiveness of
the nanoceramics is not just based on the high Z of bismuth, but also on the morphology. The
platelet structure of the Bi2O3 assists the kV radiation by providing a high surface area for xray exposure, resulting in the release of more secondary electrons and ROS. The 1.9 nm
diameter nanospheres of Au NPs produces an enhancement of equal value on less resistant
cell lines, but once the NPs are added into more resistant cells this enhancement diminishes
immediately. The breast cancer cell line used by Jain et al is less radioresistant than the 9L
gliosarcoma cells

(143)

used in this study and the other more resistive cell lines showed no

enhancement. Therefore, while the SER value for the Bi2O3 nanoceramics were lower than
the values for Jain et al, the nanoceramics are more effective than the gold. This spherical
morphology is also found in tantalum oxide which has a low kV SER but a high MV SER.
There has been a dosimetry paper published by Alqathami et al

(144)

which showed

Bi2O3 nanoceramics enhanced radiation by a factor of 1.9, but this was performed in a
SMART dosimeter, not an actual cellular environment. It fails to take into account two
factors necessary for correct characterization of a radiosensitiser since it does not use cells.
First, it does not take into account the ROS saturation effects which limit the amount of
enhancement capable of being delivered in one dose, and second, since cells were not used in
this paper, the extent of actual damage and death rates cannot be determined since cells can
repair DNA and ROS damage.
The argon annealed nanoceramic was the Bi2O3 variation chosen for 10 MV
examination because of the higher effectiveness in the kV radiation. While both materials
demonstrated the same SER, 1.31, it was the argon annealed which had the more linear of the
two curves, indicating that it was more effective at the lower doses. Therefore, if Bi2O3
nanoceramics are to be applied in a clinical setting, the argon annealed sample would be
chosen.
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5.3.2

10 MV survival curves

The results of the MV curves show that Bi2O3 nanoceramics are equally effective as gold
NPs, but not as good as tantalum. It is for the same reason that made them excellent kV
radiosensitisers, the particle morphology. Based on the Z alone, bismuth oxide should be
more effective than both the tantalum and the gold, but that is not what is observed. The
observed results show an SER equivalent to Au NPs and less than the Ta2O5 nanoceramics
because of the particle morphology. Both the Au NPs and Ta2O5 NSPs are nanospheres of 1.9
& 50 nm, compared to the platelets of Bismuth with submicron x and y dimensions, but 5080 nm thickness. These material parameters prevent secondary particles released in the bulk
of the nanoparticles from escaping the material laterally. This is a much larger issue in the
MV energies than the kV due to the low LET/ high penetration of the radiation causing less
particle generation of the surface and more in the bulk of the nanoceramic. The types of
particles produced are also very different in the MV region. The lower energies of the kVp
radiation produced primarily photoelectrons, in the ratio of Z3-4, with contributions from
Compton and Auger electrons. At 10 MV energy the primary particles being produced are
electron-positron pairs proportional to the Z2 with a contribution of Compton electrons. The
lower quantity of secondary electrons produced by the nanoceramics combined with the
dimensions of the nanoceramics reduce the effective treatment area available compared to the
kVp. The size of the nanoceramics also hinders their effectiveness through nucleus proximity
in both kVp and MV. The small metal nanoparticles, previously mentioned, are only a few
nanometres in diameters and are able to penetrate the nucleus and interact with the DNA.
When then exposed to therapeutic radiation, the secondary radiation and electrons produced
interact directly with the DNA resulting in large amounts of DSB and SSB. The Bi 2O3
nanoceramics are not that size and although they are internalised, do not distribute themselves
in the nucleus or DNA

(145)

. However, if other methods of synthesis could produce small

nanoparticles, the effectiveness in MV treatments would be increased phenomenally.

5.3.3

Chemical tailoring of nanomaterial radiosensitisers

It is a requirement for nanoparticle radiosensitisers to be biocompatible and is currently
acquired through pacifying the surface of the nanoparticles. However, we showed that
biocompatibility can be achieved through tailoring the oxygen deficiencies and ROS activity.
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From work previously done on cerium dioxide, the ROS generation/scavenging is dictated
through oxygen vacancies in the material lattice and redox activity. While Bi2O3 does not
have a reversible redox system as shown by XPS, the chemical activity was tailored for
specific cell – NP interactions through the generation of oxygen deficiencies. These tailoring
effects change the biocompatibility of the nanoceramic from cytotoxic to biocompatible in 9L
and growth enhancing in MDCK, based on the ROS scavenging/generation. The argon
annealed nanoceramic demonstrated an ROS scavenging activity due to the recombination of
the oxygen deficiencies with ROS while the air annealed showed ROS generation, up to 1.4
times the controls. This classifies Bi2O3 as an “active” radiosensitiser and opens pre- and post
radiation effects not available through the previous “passive” nanoparticles.

5.4

Proposed future research

The research into the use of bismuth oxide as a high Z radiosensitiser for cancer radiotherapy
is a novel and promising application of this well-known material. From the research
performed there are a number of directions for future research of bismuth oxide.
The first is the continual development of Bi2O3 nanoceramics for treatment of cancers
in radiation therapy as a high Z radiosensitiser. As stated in section 2.4, the high Z nature of
Bi and the inherit biocompatibility makes it highly effective as a radiosensitiser. The
nanoceramic morphology has a large influence on the effectiveness of the radiosensitisers
with the smaller spherical nanoparticles being more effective under high energy radiation,
while the platelet structure of the Bi2O3 nanoceramics proved to be highly effective in the
lower energy kV treatments. Through the use of different synthesis techniques, such as spray
pyrolosis or the newly established direct spray precipitation

(111)

, it could be possible to

reduce the size of the nanoceramics to form small platelets, which would increase the
effectiveness of the nanoceramic under high energy MV treatment while retaining the platelet
structure for kV. This has the potential to replace gold NPs as the new standard for high Z
radiosensitisers.
Secondly, due to the high Z nature of Bi2O3 and the newly shown biocompatibility
(146)

, including it in a theranostic system shows great appeal. Current theranostic systems

combine four general component agents: a carrier agent, e.g. Polyethylene Glycol (PEG), a
targeting agent (usually an amino acid) an imaging agent (like gold) and a treatment agent.
Many current theranostic systems use PEG or other carbon based polymers as the carrier
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agent because of its accepted biocompatibility and versatility as a linker. The targeting agents
are commonly amino acids as they are naturally selective and easily attached to the PEG, due
to the amine and carboxyl groups. By including bismuth oxide in a theranostic system it will
function as both the imaging and treatment agent, reducing the complexity of the system (147).
Finally, Bi2O3 has found its way into many applications with current or future
applications in health and medicine, but not much is known about its biological activity. Our
research has shown that something as simple as annealing atmosphere or annealing
temperature can change the biological activity from biocompatible to highly cytotoxic. An
investigation into the cytotoxicity and ROS activity of bismuth oxide nanoceramics with
difference phase compositions at an extensive series of time covering short term (2, 4, 6, and
12 hours) and longer term exposures (24, 48, 72 and possibly 96 hours) would help
understand the exact biological nature of the cell - nanoceramic interactions.
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6. Conclusions:
In this thesis a multi-disciplinary study was undertaken to investigate the biochemical
tailoring of bismuth oxide nanoceramics, and their effectiveness as high Z radiosensitisers for
cancer therapy. Through the use of a variety of materials characterisation techniques,
including X-ray diffraction, electron microscopy, Thermogravimetric analysis/ differential
scanning calorimetry, X-ray photoelectron spectroscopy, and UV-vis spectroscopy, it was
shown that annealing in argon instead of air, depleted the Bi2O3 of oxygen while retaining the
same material phase and morphology. The two nanoceramics were then examined in the two
cell lines, Madin Darby canine kidney and 9L rat Gliosarcoma, using clonogenic assays and
flow cytometric assays. These showed that the two nanoceramics had different biological
activities due to scavenging or generation of ROS, which enhanced cell growth in the MDCK
and was toxic to the 9L, with the extent of both effects dependent on the exposure time and
concentration of the nanoceramic.
Finally, the nanoceramics were examined for their radiosensitiser effectiveness under
kilovolt and megavolt energies. Both nanoceramics showed the same enhancement under
kilovolt energies, relatively higher than all current materials, with the more effective argon
annealed being examined in megavolt, showing itself to be on par with current
radiosensitisers. The combination of ROS activity from oxygen deficiencies and high Z
radioenhancement classify the tailored Bi2O3 as “active” radiosensitisers. Future lines of
inquiry include materials optimisation for megavolt energies, integration into a theranostic
system and biological ROS mapping.
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Appendix A

kVp filter determination

To optimise the dose enhancement effects of the bismuth oxide the correct filter and beam
energy needed to be calculated. This optimal energy was the closest to the maximum photon
absorption energy for the bismuth oxide compared to water, maximising the secondary
photoelectric particle production. Using the “xmudat” program the photo attenuation
coefficients for water and bismuth oxide were generated based on energy absorption. The
ratio between the two curves was graphed as a function of energy (keV).

Figure A1: Ratio of mass energy coefficient of Bi2O3 relative to water

The maximum differential absorption energy is around 40 keV with the K-edge being located
at 91 keV. These values were then examined against the known spectrum for the kV
orthovoltage unit at Prince of Wales Hospital and was determined that filter 4 would be the
most suitable. Filter 4 is an additional filtration of 0.1 mm Cu and 0.25 mm Al; in
combination with an X-ray tube potential of 125 kVp orthovoltage beam, it produces photons
with spectrum shown in Figure A2 and has an effective energy of 46.7 keV.
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Figure A2: The output spectrum emitted from the orthovoltage X-ray unit at 125 kVp (filter 4) at the POWH.
Source: personal communication with Dr Stéphanie Corde.

Figure A3: Output spectrum emitted from the "Bondi" linear accelerator unit at 10 MV at the POWH. Source:
personal communication with Sally McKinnon.
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Appendix B

Nanoceramic internalisation and ROS fluorescence data

The flow cytometry data was acquired using the BD FACSDiva cytometer at IHRMI using
the following parameters:

Table B1: Flow Cytometer settings

Parameter

Voltage (V)

Log

A

H

W

FSC

198

Y

Y

Y

SSC

119

Y

Y

Y

Y

515/520nm

520

Y

Y

575/526nm

588

695/640nm

668

Y

Y

780/760nm

639

Y

Y

Y

In order to analyse the data, a no-treatment control sample was gated on the plot of FSC-H,
forward scattered light intensity, and FSC-A, forward scattered peak area, to exclude data
points that were the result of doublets, two cells adhered together, or cell debris. By removing
those data points we determined the relative in shift in SSC, side scattered light, and degree
of fluorescence of 2’,7’- dichloroflurescein diacetate (H2 – DCFDA) for each nanoparticle
treatment. These results were then normalised against the no-treatment control of this gated
region. The H2 – DCFDA dye was examined using the green laser as the excitation/emission
region of the oxidised dye is 490/525nm. The fluorescence for each sample was normalised
against the controls using the relative intensities gathered by the 515/520nm detector.
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Figure B1: 9L internalisation plots

Forward scatter vs. side scatter for 9L cells. A) control at 2 hours, B) Argon annealed at 2
hours, C) Air annealed at 2 hours, D) control at 24 hours, E) Argon annealed at 24 hours and
F) Air annealed at 24 hours

Figure B2: MDCK internalisation plots
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Forward scatter vs. side scatter for MDCK cells. A) control at 2 hours, B) Argon annealed at
2 hours, C) Air annealed at 2 hours, D) control at 24 hours, E) Argon annealed at 24 hours
and F) Air annealed at 24 hours.

Figure B3: 9L fluorescence plots

Histogram of H2-DCFDA fluorescence intensity and wavelength for 9L cells: A) 2 hour
Control, B) 2 hour Argon annealed, C) 2 hour Air annealed, D) 24 hour Control, E) 24 hour
Argon and F) 24 hour Air annealed.
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Figure B4: MDCK fluorescence plots

Histogram of H2-DCFDA fluorescence intensity and wavelength for MDCK cells: A) 2 hour
Control, B) 2 hour Argon annealed, C) 2 hour Air annealed, D) 24 hour Control, E) 24 hour
Argon and F) 24 hour Air annealed.
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